[
  {
    "title": "15 Best S&P 500 Dividend Stocks To Buy Now",
    "published": 1715107844,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 163.36000061035156,
      "2024-05-07T14:30:00+00:00": 163.50999450683594,
      "2024-05-07T15:30:00+00:00": 162.72999572753906,
      "2024-05-07T16:30:00+00:00": 162.3300018310547,
      "2024-05-07T17:30:00+00:00": 162.52000427246094,
      "2024-05-07T18:30:00+00:00": 162.125,
      "2024-05-07T19:30:00+00:00": 162.5
    },
    "sentiment": 0.8917243480682373
  },
  {
    "title": "3 Top Dividend Stocks to Maximize Your Retirement Income",
    "published": 1715001003,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 164.41000366210938,
      "2024-05-06T14:30:00+00:00": 161.3300018310547,
      "2024-05-06T15:30:00+00:00": 162.02999877929688,
      "2024-05-06T16:30:00+00:00": 161.8300018310547,
      "2024-05-06T17:30:00+00:00": 162.3249969482422,
      "2024-05-06T18:30:00+00:00": 162.55999755859375,
      "2024-05-06T19:30:00+00:00": 162.02000427246094
    },
    "sentiment": 0.8918992877006531
  },
  {
    "title": "AbbVie to Present at the Bank of America Securities Healthcare Conference",
    "published": 1714996800,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 164.41000366210938,
      "2024-05-06T14:30:00+00:00": 161.3300018310547,
      "2024-05-06T15:30:00+00:00": 162.02999877929688,
      "2024-05-06T16:30:00+00:00": 161.8300018310547,
      "2024-05-06T17:30:00+00:00": 162.3249969482422,
      "2024-05-06T18:30:00+00:00": 162.55999755859375,
      "2024-05-06T19:30:00+00:00": 162.02000427246094
    },
    "sentiment": 0.9339443445205688
  },
  {
    "title": "3 Biotech Stocks to Double Your Money in the Next 24 Months",
    "published": 1714959300,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 164.41000366210938,
      "2024-05-06T14:30:00+00:00": 161.3300018310547,
      "2024-05-06T15:30:00+00:00": 162.02999877929688,
      "2024-05-06T16:30:00+00:00": 161.8300018310547,
      "2024-05-06T17:30:00+00:00": 162.3249969482422,
      "2024-05-06T18:30:00+00:00": 162.55999755859375,
      "2024-05-06T19:30:00+00:00": 162.02000427246094
    },
    "sentiment": 0.7702028155326843
  },
  {
    "title": "Decoding AbbVie Inc (ABBV): A Strategic SWOT Insight",
    "published": 1714798875,
    "day_prices": {},
    "sentiment": 0.9077977538108826
  },
  {
    "title": "Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims",
    "published": 1714750140,
    "day_prices": {
      "2024-05-03T13:30:00+00:00": 161.1300048828125,
      "2024-05-03T14:30:00+00:00": 162.10000610351562,
      "2024-05-03T15:30:00+00:00": 162.3300018310547,
      "2024-05-03T16:30:00+00:00": 162.7899932861328,
      "2024-05-03T17:30:00+00:00": 163.19000244140625,
      "2024-05-03T18:30:00+00:00": 163.72999572753906,
      "2024-05-03T19:30:00+00:00": 163.82000732421875
    },
    "sentiment": 0.6807330250740051
  },
  {
    "title": "ABBV June 14th Options Begin Trading",
    "published": 1714733340,
    "day_prices": {
      "2024-05-03T13:30:00+00:00": 161.1300048828125,
      "2024-05-03T14:30:00+00:00": 162.10000610351562,
      "2024-05-03T15:30:00+00:00": 162.3300018310547,
      "2024-05-03T16:30:00+00:00": 162.7899932861328,
      "2024-05-03T17:30:00+00:00": 163.19000244140625,
      "2024-05-03T18:30:00+00:00": 163.72999572753906,
      "2024-05-03T19:30:00+00:00": 163.82000732421875
    },
    "sentiment": 0.9349246621131897
  },
  {
    "title": "Genmab reports Q1 revenue increased 46% vs. last year",
    "published": 1714644360,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 162.1699981689453,
      "2024-05-02T14:30:00+00:00": 159.09500122070312,
      "2024-05-02T15:30:00+00:00": 160.0,
      "2024-05-02T16:30:00+00:00": 159.3000030517578,
      "2024-05-02T17:30:00+00:00": 159.5,
      "2024-05-02T18:30:00+00:00": 159.72000122070312,
      "2024-05-02T19:30:00+00:00": 160.5399932861328
    },
    "sentiment": 0.9575232267379761
  },
  {
    "title": "$1000 Invested In This Stock 10 Years Ago Would Be Worth $3,100 Today",
    "published": 1714613760,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 162.1699981689453,
      "2024-05-02T14:30:00+00:00": 159.09500122070312,
      "2024-05-02T15:30:00+00:00": 160.0,
      "2024-05-02T16:30:00+00:00": 159.3000030517578,
      "2024-05-02T17:30:00+00:00": 159.5,
      "2024-05-02T18:30:00+00:00": 159.72000122070312,
      "2024-05-02T19:30:00+00:00": 160.5399932861328
    },
    "sentiment": 0.9494220614433289
  },
  {
    "title": "Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock",
    "published": 1714568416,
    "day_prices": {
      "2024-05-01T13:30:00+00:00": 162.08999633789062,
      "2024-05-01T14:30:00+00:00": 162.10000610351562,
      "2024-05-01T15:30:00+00:00": 162.85000610351562,
      "2024-05-01T16:30:00+00:00": 163.30999755859375,
      "2024-05-01T17:30:00+00:00": 163.36000061035156,
      "2024-05-01T18:30:00+00:00": 162.2100067138672,
      "2024-05-01T19:30:00+00:00": 162.86000061035156
    },
    "sentiment": 0.8846345543861389
  },
  {
    "title": "Novartis Is Tracking Well Above the Industry",
    "published": 1714550460,
    "day_prices": {
      "2024-05-01T13:30:00+00:00": 162.08999633789062,
      "2024-05-01T14:30:00+00:00": 162.10000610351562,
      "2024-05-01T15:30:00+00:00": 162.85000610351562,
      "2024-05-01T16:30:00+00:00": 163.30999755859375,
      "2024-05-01T17:30:00+00:00": 163.36000061035156,
      "2024-05-01T18:30:00+00:00": 162.2100067138672,
      "2024-05-01T19:30:00+00:00": 162.86000061035156
    },
    "sentiment": 0.8905430436134338
  },
  {
    "title": "2 Fortune 100 Best Co's To Work For Are Also Good To Own",
    "published": 1715787420,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 162.30999755859375,
      "2024-05-15T14:30:00+00:00": 162.88499450683594,
      "2024-05-15T15:30:00+00:00": 163.42999267578125,
      "2024-05-15T16:30:00+00:00": 163.0800018310547,
      "2024-05-15T17:30:00+00:00": 163.38499450683594,
      "2024-05-15T18:30:00+00:00": 163.52999877929688,
      "2024-05-15T19:30:00+00:00": 163.38999938964844
    },
    "sentiment": 0.8121541142463684
  },
  {
    "title": "Pfizer: Best Trading Momentum Since 2021 And 6% Yield",
    "published": 1715762736,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 162.30999755859375,
      "2024-05-15T14:30:00+00:00": 162.88499450683594,
      "2024-05-15T15:30:00+00:00": 163.42999267578125,
      "2024-05-15T16:30:00+00:00": 163.0800018310547,
      "2024-05-15T17:30:00+00:00": 163.38499450683594,
      "2024-05-15T18:30:00+00:00": 163.52999877929688,
      "2024-05-15T19:30:00+00:00": 163.38999938964844
    },
    "sentiment": 0.938089907169342
  },
  {
    "title": "AbbVie (ABBV) Boosts Neuropsychiatric Portfolio With New Deal",
    "published": 1715703000,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 161.64999389648438,
      "2024-05-14T14:30:00+00:00": 160.4499969482422,
      "2024-05-14T15:30:00+00:00": 160.82000732421875,
      "2024-05-14T16:30:00+00:00": 160.0800018310547,
      "2024-05-14T17:30:00+00:00": 159.97000122070312,
      "2024-05-14T18:30:00+00:00": 160.86000061035156,
      "2024-05-14T19:30:00+00:00": 161.1999969482422
    },
    "sentiment": 0.9454495310783386
  },
  {
    "title": "Unpacking the Latest Options Trading Trends in AbbVie",
    "published": 1715690040,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 161.64999389648438,
      "2024-05-14T14:30:00+00:00": 160.4499969482422,
      "2024-05-14T15:30:00+00:00": 160.82000732421875,
      "2024-05-14T16:30:00+00:00": 160.0800018310547,
      "2024-05-14T17:30:00+00:00": 159.97000122070312,
      "2024-05-14T18:30:00+00:00": 160.86000061035156,
      "2024-05-14T19:30:00+00:00": 161.1999969482422
    },
    "sentiment": 0.9223025441169739
  },
  {
    "title": "3 Magnificent Stocks That Are Passive Income Machines",
    "published": 1715682600,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 161.64999389648438,
      "2024-05-14T14:30:00+00:00": 160.4499969482422,
      "2024-05-14T15:30:00+00:00": 160.82000732421875,
      "2024-05-14T16:30:00+00:00": 160.0800018310547,
      "2024-05-14T17:30:00+00:00": 159.97000122070312,
      "2024-05-14T18:30:00+00:00": 160.86000061035156,
      "2024-05-14T19:30:00+00:00": 161.1999969482422
    },
    "sentiment": 0.9103230834007263
  },
  {
    "title": "Unlocking Intrinsic Value: Analysis of AbbVie Inc",
    "published": 1715666460,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 161.64999389648438,
      "2024-05-14T14:30:00+00:00": 160.4499969482422,
      "2024-05-14T15:30:00+00:00": 160.82000732421875,
      "2024-05-14T16:30:00+00:00": 160.0800018310547,
      "2024-05-14T17:30:00+00:00": 159.97000122070312,
      "2024-05-14T18:30:00+00:00": 160.86000061035156,
      "2024-05-14T19:30:00+00:00": 161.1999969482422
    },
    "sentiment": 0.876078188419342
  },
  {
    "title": "12 Undervalued Stocks That Just Raised Their Dividends",
    "published": 1715615064,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 161.27999877929688,
      "2024-05-13T14:30:00+00:00": 161.72999572753906,
      "2024-05-13T15:30:00+00:00": 161.9499969482422,
      "2024-05-13T16:30:00+00:00": 161.45790100097656,
      "2024-05-13T17:30:00+00:00": 161.07000732421875,
      "2024-05-13T18:30:00+00:00": 161.52000427246094,
      "2024-05-13T19:30:00+00:00": 161.40499877929688
    },
    "sentiment": 0.5236473679542542
  },
  {
    "title": "AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disorders",
    "published": 1715603880,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 161.27999877929688,
      "2024-05-13T14:30:00+00:00": 161.72999572753906,
      "2024-05-13T15:30:00+00:00": 161.9499969482422,
      "2024-05-13T16:30:00+00:00": 161.45790100097656,
      "2024-05-13T17:30:00+00:00": 161.07000732421875,
      "2024-05-13T18:30:00+00:00": 161.52000427246094,
      "2024-05-13T19:30:00+00:00": 161.40499877929688
    },
    "sentiment": 0.910262405872345
  },
  {
    "title": "See Which Of The Latest 13F Filers Holds AbbVie",
    "published": 1715599440,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 161.27999877929688,
      "2024-05-13T14:30:00+00:00": 161.72999572753906,
      "2024-05-13T15:30:00+00:00": 161.9499969482422,
      "2024-05-13T16:30:00+00:00": 161.45790100097656,
      "2024-05-13T17:30:00+00:00": 161.07000732421875,
      "2024-05-13T18:30:00+00:00": 161.52000427246094,
      "2024-05-13T19:30:00+00:00": 161.40499877929688
    },
    "sentiment": 0.9429993033409119
  },
  {
    "title": "AbbVie, Gilgamesh Pharmaceuticals to co-develop psychiatric disorder therapies",
    "published": 1715586120,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 161.27999877929688,
      "2024-05-13T14:30:00+00:00": 161.72999572753906,
      "2024-05-13T15:30:00+00:00": 161.9499969482422,
      "2024-05-13T16:30:00+00:00": 161.45790100097656,
      "2024-05-13T17:30:00+00:00": 161.07000732421875,
      "2024-05-13T18:30:00+00:00": 161.52000427246094,
      "2024-05-13T19:30:00+00:00": 161.40499877929688
    },
    "sentiment": 0.7757079601287842
  },
  {
    "title": "My Dividend Growth Portfolio: Selling Bio-Pharma And Buying More Big-Tech",
    "published": 1715573169,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 161.27999877929688,
      "2024-05-13T14:30:00+00:00": 161.72999572753906,
      "2024-05-13T15:30:00+00:00": 161.9499969482422,
      "2024-05-13T16:30:00+00:00": 161.45790100097656,
      "2024-05-13T17:30:00+00:00": 161.07000732421875,
      "2024-05-13T18:30:00+00:00": 161.52000427246094,
      "2024-05-13T19:30:00+00:00": 161.40499877929688
    },
    "sentiment": 0.8112061619758606
  },
  {
    "title": "Robert Bruce's Strategic Moves in Q1 2024: Spotlight on Xcel Energy Inc",
    "published": 1715569320,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 161.27999877929688,
      "2024-05-13T14:30:00+00:00": 161.72999572753906,
      "2024-05-13T15:30:00+00:00": 161.9499969482422,
      "2024-05-13T16:30:00+00:00": 161.45790100097656,
      "2024-05-13T17:30:00+00:00": 161.07000732421875,
      "2024-05-13T18:30:00+00:00": 161.52000427246094,
      "2024-05-13T19:30:00+00:00": 161.40499877929688
    },
    "sentiment": 0.8593848943710327
  },
  {
    "title": "Earn $1000 Every Month From These 3 Stocks",
    "published": 1715431080,
    "day_prices": {},
    "sentiment": 0.9170083403587341
  },
  {
    "title": "Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.",
    "published": 1715413800,
    "day_prices": {},
    "sentiment": 0.9331989288330078
  },
  {
    "title": "Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates",
    "published": 1715354160,
    "day_prices": {
      "2024-05-10T13:30:00+00:00": 160.7100067138672,
      "2024-05-10T14:30:00+00:00": 160.82000732421875,
      "2024-05-10T15:30:00+00:00": 160.72000122070312,
      "2024-05-10T16:30:00+00:00": 160.7180938720703,
      "2024-05-10T17:30:00+00:00": 160.88999938964844,
      "2024-05-10T18:30:00+00:00": 161.10000610351562,
      "2024-05-10T19:30:00+00:00": 160.72999572753906
    },
    "sentiment": 0.9718490242958069
  },
  {
    "title": "(ABBV) - Analyzing AbbVie's Short Interest",
    "published": 1715307480,
    "day_prices": {
      "2024-05-10T13:30:00+00:00": 160.7100067138672,
      "2024-05-10T14:30:00+00:00": 160.82000732421875,
      "2024-05-10T15:30:00+00:00": 160.72000122070312,
      "2024-05-10T16:30:00+00:00": 160.7180938720703,
      "2024-05-10T17:30:00+00:00": 160.88999938964844,
      "2024-05-10T18:30:00+00:00": 161.10000610351562,
      "2024-05-10T19:30:00+00:00": 160.72999572753906
    },
    "sentiment": 0.9454969763755798
  },
  {
    "title": "Teva Pharmaceutical: 6 Takeaways From Q1 2024 Earnings Results",
    "published": 1715242500,
    "day_prices": {
      "2024-05-09T13:30:00+00:00": 160.80499267578125,
      "2024-05-09T14:30:00+00:00": 160.8300018310547,
      "2024-05-09T15:30:00+00:00": 161.0,
      "2024-05-09T16:30:00+00:00": 160.52000427246094,
      "2024-05-09T17:30:00+00:00": 160.5449981689453,
      "2024-05-09T18:30:00+00:00": 160.3300018310547,
      "2024-05-09T19:30:00+00:00": 160.39999389648438
    },
    "sentiment": 0.6446048021316528
  },
  {
    "title": "Teva Stock Is Powering Ahead as Schizophrenia News Offsets Mixed Earnings",
    "published": 1715175420,
    "day_prices": {
      "2024-05-08T13:30:00+00:00": 162.13999938964844,
      "2024-05-08T14:30:00+00:00": 160.36000061035156,
      "2024-05-08T15:30:00+00:00": 160.36500549316406,
      "2024-05-08T16:30:00+00:00": 160.02000427246094,
      "2024-05-08T17:30:00+00:00": 160.24949645996094,
      "2024-05-08T18:30:00+00:00": 160.13999938964844,
      "2024-05-08T19:30:00+00:00": 160.77000427246094
    },
    "sentiment": 0.8549548387527466
  },
  {
    "title": "BofA starts Sutro at buy, cites ovarian cancer drug candidate",
    "published": 1715164440,
    "day_prices": {
      "2024-05-08T13:30:00+00:00": 162.13999938964844,
      "2024-05-08T14:30:00+00:00": 160.36000061035156,
      "2024-05-08T15:30:00+00:00": 160.36500549316406,
      "2024-05-08T16:30:00+00:00": 160.02000427246094,
      "2024-05-08T17:30:00+00:00": 160.24949645996094,
      "2024-05-08T18:30:00+00:00": 160.13999938964844,
      "2024-05-08T19:30:00+00:00": 160.77000427246094
    },
    "sentiment": 0.8877922892570496
  },
  {
    "title": "3 Biotech Stocks to Buy on the Dip: May 2024",
    "published": 1716487274,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 159.02999877929688,
      "2024-05-23T14:30:00+00:00": 159.1999969482422,
      "2024-05-23T15:30:00+00:00": 159.2550048828125,
      "2024-05-23T16:30:00+00:00": 159.8300018310547,
      "2024-05-23T17:30:00+00:00": 159.32000732421875,
      "2024-05-23T18:30:00+00:00": 159.00999450683594,
      "2024-05-23T19:30:00+00:00": 158.64999389648438
    },
    "sentiment": 0.8900655508041382
  },
  {
    "title": "8 Health Care Stocks Whale Activity In Today's Session",
    "published": 1716467940,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 159.02999877929688,
      "2024-05-23T14:30:00+00:00": 159.1999969482422,
      "2024-05-23T15:30:00+00:00": 159.2550048828125,
      "2024-05-23T16:30:00+00:00": 159.8300018310547,
      "2024-05-23T17:30:00+00:00": 159.32000732421875,
      "2024-05-23T18:30:00+00:00": 159.00999450683594,
      "2024-05-23T19:30:00+00:00": 158.64999389648438
    },
    "sentiment": 0.7666309475898743
  },
  {
    "title": "The 100%+ Club: Piper Sandler\u2019s 3 Top Picks for Triple-Digit Gains",
    "published": 1716425447,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 159.02999877929688,
      "2024-05-23T14:30:00+00:00": 159.1999969482422,
      "2024-05-23T15:30:00+00:00": 159.2550048828125,
      "2024-05-23T16:30:00+00:00": 159.8300018310547,
      "2024-05-23T17:30:00+00:00": 159.32000732421875,
      "2024-05-23T18:30:00+00:00": 159.00999450683594,
      "2024-05-23T19:30:00+00:00": 158.64999389648438
    },
    "sentiment": 0.8413353562355042
  },
  {
    "title": "Add These Dividend Stocks To Your Portfolio To Boost Your Retirement Income, Plus 2 High-Yield Alternatives",
    "published": 1716387886,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 161.57000732421875,
      "2024-05-22T14:30:00+00:00": 160.85499572753906,
      "2024-05-22T15:30:00+00:00": 160.25,
      "2024-05-22T16:30:00+00:00": 159.3800048828125,
      "2024-05-22T17:30:00+00:00": 160.79510498046875,
      "2024-05-22T18:30:00+00:00": 160.64500427246094,
      "2024-05-22T19:30:00+00:00": 160.47000122070312
    },
    "sentiment": 0.572674036026001
  },
  {
    "title": "A Must-Own Stock for Any Portfolio",
    "published": 1716381720,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 161.57000732421875,
      "2024-05-22T14:30:00+00:00": 160.85499572753906,
      "2024-05-22T15:30:00+00:00": 160.25,
      "2024-05-22T16:30:00+00:00": 159.3800048828125,
      "2024-05-22T17:30:00+00:00": 160.79510498046875,
      "2024-05-22T18:30:00+00:00": 160.64500427246094,
      "2024-05-22T19:30:00+00:00": 160.47000122070312
    },
    "sentiment": 0.9525187611579895
  },
  {
    "title": "2 Billion More Reasons to Buy AbbVie Stock",
    "published": 1716374700,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 161.57000732421875,
      "2024-05-22T14:30:00+00:00": 160.85499572753906,
      "2024-05-22T15:30:00+00:00": 160.25,
      "2024-05-22T16:30:00+00:00": 159.3800048828125,
      "2024-05-22T17:30:00+00:00": 160.79510498046875,
      "2024-05-22T18:30:00+00:00": 160.64500427246094,
      "2024-05-22T19:30:00+00:00": 160.47000122070312
    },
    "sentiment": 0.9249847531318665
  },
  {
    "title": "Pfizer: Offsetting The LOE Cliff Crisis With 6 New Potential Blockbuster Drugs",
    "published": 1716285600,
    "day_prices": {
      "2024-05-21T13:30:00+00:00": 165.3699951171875,
      "2024-05-21T14:30:00+00:00": 163.07000732421875,
      "2024-05-21T15:30:00+00:00": 163.44000244140625,
      "2024-05-21T16:30:00+00:00": 162.86000061035156,
      "2024-05-21T17:30:00+00:00": 162.6300048828125,
      "2024-05-21T18:30:00+00:00": 162.60000610351562,
      "2024-05-21T19:30:00+00:00": 162.9499969482422
    },
    "sentiment": 0.8975399136543274
  },
  {
    "title": "AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week",
    "published": 1716199950,
    "day_prices": {
      "2024-05-20T13:30:00+00:00": 166.00999450683594,
      "2024-05-20T14:30:00+00:00": 165.75999450683594,
      "2024-05-20T15:30:00+00:00": 165.66229248046875,
      "2024-05-20T16:30:00+00:00": 165.41000366210938,
      "2024-05-20T17:30:00+00:00": 165.3105010986328,
      "2024-05-20T18:30:00+00:00": 165.4499969482422,
      "2024-05-20T19:30:00+00:00": 165.05999755859375
    },
    "sentiment": 0.7140294313430786
  },
  {
    "title": "SA Roundtable: Are Eli Lilly and Novo Nordisk overvalued?",
    "published": 1716084420,
    "day_prices": {},
    "sentiment": 0.8515270948410034
  },
  {
    "title": "Robinhood upgraded, Baidu downgraded: Wall Street's top analyst calls",
    "published": 1715953129,
    "day_prices": {
      "2024-05-17T13:30:00+00:00": 165.38999938964844,
      "2024-05-17T14:30:00+00:00": 165.0500030517578,
      "2024-05-17T15:30:00+00:00": 165.27999877929688,
      "2024-05-17T16:30:00+00:00": 165.69000244140625,
      "2024-05-17T17:30:00+00:00": 166.35000610351562,
      "2024-05-17T18:30:00+00:00": 166.22999572753906,
      "2024-05-17T19:30:00+00:00": 166.24000549316406
    },
    "sentiment": 0.4077283442020416
  },
  {
    "title": "AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion':  Analyst",
    "published": 1715950380,
    "day_prices": {
      "2024-05-17T13:30:00+00:00": 165.38999938964844,
      "2024-05-17T14:30:00+00:00": 165.0500030517578,
      "2024-05-17T15:30:00+00:00": 165.27999877929688,
      "2024-05-17T16:30:00+00:00": 165.69000244140625,
      "2024-05-17T17:30:00+00:00": 166.35000610351562,
      "2024-05-17T18:30:00+00:00": 166.22999572753906,
      "2024-05-17T19:30:00+00:00": 166.24000549316406
    },
    "sentiment": 0.9092690348625183
  },
  {
    "title": "7 Value Stocks to Buy and Hold for a Decade of Dominance",
    "published": 1715944260,
    "day_prices": {
      "2024-05-17T13:30:00+00:00": 165.38999938964844,
      "2024-05-17T14:30:00+00:00": 165.0500030517578,
      "2024-05-17T15:30:00+00:00": 165.27999877929688,
      "2024-05-17T16:30:00+00:00": 165.69000244140625,
      "2024-05-17T17:30:00+00:00": 166.35000610351562,
      "2024-05-17T18:30:00+00:00": 166.22999572753906,
      "2024-05-17T19:30:00+00:00": 166.24000549316406
    },
    "sentiment": 0.9146937727928162
  },
  {
    "title": "The Analyst Verdict: AbbVie In The Eyes Of 5 Experts",
    "published": 1715933160,
    "day_prices": {
      "2024-05-17T13:30:00+00:00": 165.38999938964844,
      "2024-05-17T14:30:00+00:00": 165.0500030517578,
      "2024-05-17T15:30:00+00:00": 165.27999877929688,
      "2024-05-17T16:30:00+00:00": 165.69000244140625,
      "2024-05-17T17:30:00+00:00": 166.35000610351562,
      "2024-05-17T18:30:00+00:00": 166.22999572753906,
      "2024-05-17T19:30:00+00:00": 166.24000549316406
    },
    "sentiment": 0.6888388395309448
  },
  {
    "title": "AbbVie initiated with bullish view at Cantor Fitzgerald",
    "published": 1715922600,
    "day_prices": {
      "2024-05-17T13:30:00+00:00": 165.38999938964844,
      "2024-05-17T14:30:00+00:00": 165.0500030517578,
      "2024-05-17T15:30:00+00:00": 165.27999877929688,
      "2024-05-17T16:30:00+00:00": 165.69000244140625,
      "2024-05-17T17:30:00+00:00": 166.35000610351562,
      "2024-05-17T18:30:00+00:00": 166.22999572753906,
      "2024-05-17T19:30:00+00:00": 166.24000549316406
    },
    "sentiment": 0.8167566061019897
  },
  {
    "title": "AbbVie CEO latest heavy hitter to buy in Boca Raton",
    "published": 1715887800,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 163.4499969482422,
      "2024-05-16T14:30:00+00:00": 162.85000610351562,
      "2024-05-16T15:30:00+00:00": 162.8090057373047,
      "2024-05-16T16:30:00+00:00": 163.25999450683594,
      "2024-05-16T17:30:00+00:00": 163.55999755859375,
      "2024-05-16T18:30:00+00:00": 163.9149932861328,
      "2024-05-16T19:30:00+00:00": 164.22000122070312
    },
    "sentiment": 0.8461467027664185
  },
  {
    "title": "$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,000 Today",
    "published": 1715859360,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 163.4499969482422,
      "2024-05-16T14:30:00+00:00": 162.85000610351562,
      "2024-05-16T15:30:00+00:00": 162.8090057373047,
      "2024-05-16T16:30:00+00:00": 163.25999450683594,
      "2024-05-16T17:30:00+00:00": 163.55999755859375,
      "2024-05-16T18:30:00+00:00": 163.9149932861328,
      "2024-05-16T19:30:00+00:00": 164.22000122070312
    },
    "sentiment": 0.9496921300888062
  },
  {
    "title": "AbbVie wins EU backing for Skyrizi in bowel disorder",
    "published": 1717135980,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 156.64999389648438,
      "2024-05-31T14:30:00+00:00": 157.5449981689453,
      "2024-05-31T15:30:00+00:00": 157.33999633789062,
      "2024-05-31T16:30:00+00:00": 157.51499938964844,
      "2024-05-31T17:30:00+00:00": 157.92999267578125,
      "2024-05-31T18:30:00+00:00": 158.26499938964844,
      "2024-05-31T19:30:00+00:00": 158.7100067138672
    },
    "sentiment": 0.8550795316696167
  },
  {
    "title": "IN BRIEF: AbbVie's risankizumab gets EMA recommendation",
    "published": 1717134720,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 156.64999389648438,
      "2024-05-31T14:30:00+00:00": 157.5449981689453,
      "2024-05-31T15:30:00+00:00": 157.33999633789062,
      "2024-05-31T16:30:00+00:00": 157.51499938964844,
      "2024-05-31T17:30:00+00:00": 157.92999267578125,
      "2024-05-31T18:30:00+00:00": 158.26499938964844,
      "2024-05-31T19:30:00+00:00": 158.7100067138672
    },
    "sentiment": 0.5029850006103516
  },
  {
    "title": "AbbVie: Turnaround Lurking After The Correction Pain (Upgrade)",
    "published": 1717068600,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 154.64999389648438,
      "2024-05-30T14:30:00+00:00": 154.74000549316406,
      "2024-05-30T15:30:00+00:00": 155.63999938964844,
      "2024-05-30T16:30:00+00:00": 155.41000366210938,
      "2024-05-30T17:30:00+00:00": 155.72000122070312,
      "2024-05-30T18:30:00+00:00": 155.6199951171875,
      "2024-05-30T19:30:00+00:00": 156.0399932861328
    },
    "sentiment": 0.7167714238166809
  },
  {
    "title": "AbbVie: This Dividend Aristocrat Is Almost Buyable Again Now",
    "published": 1717053300,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 154.64999389648438,
      "2024-05-30T14:30:00+00:00": 154.74000549316406,
      "2024-05-30T15:30:00+00:00": 155.63999938964844,
      "2024-05-30T16:30:00+00:00": 155.41000366210938,
      "2024-05-30T17:30:00+00:00": 155.72000122070312,
      "2024-05-30T18:30:00+00:00": 155.6199951171875,
      "2024-05-30T19:30:00+00:00": 156.0399932861328
    },
    "sentiment": 0.6398485898971558
  },
  {
    "title": "Looking For Both Income And Growth? 4%-Yielding AbbVie Has You Covered",
    "published": 1717002606,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 154.88999938964844,
      "2024-05-29T14:30:00+00:00": 155.8000030517578,
      "2024-05-29T15:30:00+00:00": 154.6999969482422,
      "2024-05-29T16:30:00+00:00": 154.3800048828125,
      "2024-05-29T17:30:00+00:00": 154.5,
      "2024-05-29T18:30:00+00:00": 153.89500427246094,
      "2024-05-29T19:30:00+00:00": 154.10499572753906
    },
    "sentiment": 0.8356914520263672
  },
  {
    "title": "AbbVie shares fell for seven straight days",
    "published": 1716952500,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 154.88999938964844,
      "2024-05-29T14:30:00+00:00": 155.8000030517578,
      "2024-05-29T15:30:00+00:00": 154.6999969482422,
      "2024-05-29T16:30:00+00:00": 154.3800048828125,
      "2024-05-29T17:30:00+00:00": 154.5,
      "2024-05-29T18:30:00+00:00": 153.89500427246094,
      "2024-05-29T19:30:00+00:00": 154.10499572753906
    },
    "sentiment": 0.9705638885498047
  },
  {
    "title": "AbbVie to present new antitumor data from ADC platform",
    "published": 1716880020,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 156.35000610351562,
      "2024-05-28T14:30:00+00:00": 154.8249969482422,
      "2024-05-28T15:30:00+00:00": 155.4149932861328,
      "2024-05-28T16:30:00+00:00": 154.89999389648438,
      "2024-05-28T17:30:00+00:00": 154.3800048828125,
      "2024-05-28T18:30:00+00:00": 154.14999389648438,
      "2024-05-28T19:30:00+00:00": 154.1999969482422
    },
    "sentiment": 0.9150224924087524
  },
  {
    "title": "ABBV Crosses Above 4% Yield Territory",
    "published": 1716866880,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 156.35000610351562,
      "2024-05-28T14:30:00+00:00": 154.8249969482422,
      "2024-05-28T15:30:00+00:00": 155.4149932861328,
      "2024-05-28T16:30:00+00:00": 154.89999389648438,
      "2024-05-28T17:30:00+00:00": 154.3800048828125,
      "2024-05-28T18:30:00+00:00": 154.14999389648438,
      "2024-05-28T19:30:00+00:00": 154.1999969482422
    },
    "sentiment": 0.9391123652458191
  },
  {
    "title": "Unloved Gilead Due For Reversal On Flight-To-Safety Money Flows",
    "published": 1716814140,
    "day_prices": {},
    "sentiment": 0.9099150896072388
  },
  {
    "title": "Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever",
    "published": 1716630360,
    "day_prices": {},
    "sentiment": 0.9345173239707947
  },
  {
    "title": "How To Invest $1 Million For Steady Income And Growth",
    "published": 1716627600,
    "day_prices": {},
    "sentiment": 0.8919657468795776
  },
  {
    "title": "10 Health Care Stocks With Whale Alerts In Today's Session",
    "published": 1716554400,
    "day_prices": {
      "2024-05-24T13:30:00+00:00": 158.36000061035156,
      "2024-05-24T14:30:00+00:00": 157.67999267578125,
      "2024-05-24T15:30:00+00:00": 157.52999877929688,
      "2024-05-24T16:30:00+00:00": 157.3000030517578,
      "2024-05-24T17:30:00+00:00": 156.9600067138672,
      "2024-05-24T18:30:00+00:00": 156.6009979248047,
      "2024-05-24T19:30:00+00:00": 156.4499969482422
    },
    "sentiment": 0.8725749254226685
  },
  {
    "title": "Sell Alert: 2 Dividend Stocks To Sell In May And Go Away",
    "published": 1716548624,
    "day_prices": {
      "2024-05-24T13:30:00+00:00": 158.36000061035156,
      "2024-05-24T14:30:00+00:00": 157.67999267578125,
      "2024-05-24T15:30:00+00:00": 157.52999877929688,
      "2024-05-24T16:30:00+00:00": 157.3000030517578,
      "2024-05-24T17:30:00+00:00": 156.9600067138672,
      "2024-05-24T18:30:00+00:00": 156.6009979248047,
      "2024-05-24T19:30:00+00:00": 156.4499969482422
    },
    "sentiment": 0.9367433786392212
  },
  {
    "title": "If I Had To Retire With 10 Dividend Aristocrats, It Would Be These",
    "published": 1719743745,
    "day_prices": {},
    "sentiment": 0.9304025769233704
  },
  {
    "title": "How Medicare drug price negotiations could hit pharma stocks",
    "published": 1719607022,
    "day_prices": {
      "2024-06-28T13:30:00+00:00": 169.99000549316406,
      "2024-06-28T14:30:00+00:00": 169.38999938964844,
      "2024-06-28T15:30:00+00:00": 169.5749969482422,
      "2024-06-28T16:30:00+00:00": 169.57000732421875,
      "2024-06-28T17:30:00+00:00": 169.6999969482422,
      "2024-06-28T18:30:00+00:00": 170.1999969482422,
      "2024-06-28T19:30:00+00:00": 170.02999877929688
    },
    "sentiment": 0.7514237761497498
  },
  {
    "title": "AbbVie Insiders Sold US$56m Of Shares Suggesting Hesitancy",
    "published": 1719583214,
    "day_prices": {
      "2024-06-28T13:30:00+00:00": 169.99000549316406,
      "2024-06-28T14:30:00+00:00": 169.38999938964844,
      "2024-06-28T15:30:00+00:00": 169.5749969482422,
      "2024-06-28T16:30:00+00:00": 169.57000732421875,
      "2024-06-28T17:30:00+00:00": 169.6999969482422,
      "2024-06-28T18:30:00+00:00": 170.1999969482422,
      "2024-06-28T19:30:00+00:00": 170.02999877929688
    },
    "sentiment": 0.8734114766120911
  },
  {
    "title": "AbbVie's (ABBV) Celsius Therapeutics Deal to Boost IBD Presence",
    "published": 1719579060,
    "day_prices": {
      "2024-06-28T13:30:00+00:00": 169.99000549316406,
      "2024-06-28T14:30:00+00:00": 169.38999938964844,
      "2024-06-28T15:30:00+00:00": 169.5749969482422,
      "2024-06-28T16:30:00+00:00": 169.57000732421875,
      "2024-06-28T17:30:00+00:00": 169.6999969482422,
      "2024-06-28T18:30:00+00:00": 170.1999969482422,
      "2024-06-28T19:30:00+00:00": 170.02999877929688
    },
    "sentiment": 0.9530256390571594
  },
  {
    "title": "7 Dividend Kings to Buy With Your Roth IRA Money in 2024",
    "published": 1719569580,
    "day_prices": {
      "2024-06-28T13:30:00+00:00": 169.99000549316406,
      "2024-06-28T14:30:00+00:00": 169.38999938964844,
      "2024-06-28T15:30:00+00:00": 169.5749969482422,
      "2024-06-28T16:30:00+00:00": 169.57000732421875,
      "2024-06-28T17:30:00+00:00": 169.6999969482422,
      "2024-06-28T18:30:00+00:00": 170.1999969482422,
      "2024-06-28T19:30:00+00:00": 170.02999877929688
    },
    "sentiment": 0.9169039726257324
  },
  {
    "title": "AbbVie, Genmab blood cancer therapy endorsed in EU",
    "published": 1719563580,
    "day_prices": {
      "2024-06-28T13:30:00+00:00": 169.99000549316406,
      "2024-06-28T14:30:00+00:00": 169.38999938964844,
      "2024-06-28T15:30:00+00:00": 169.5749969482422,
      "2024-06-28T16:30:00+00:00": 169.57000732421875,
      "2024-06-28T17:30:00+00:00": 169.6999969482422,
      "2024-06-28T18:30:00+00:00": 170.1999969482422,
      "2024-06-28T19:30:00+00:00": 170.02999877929688
    },
    "sentiment": 0.8387517333030701
  },
  {
    "title": "AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY\u00ae) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma",
    "published": 1719554400,
    "day_prices": {
      "2024-06-28T13:30:00+00:00": 169.99000549316406,
      "2024-06-28T14:30:00+00:00": 169.38999938964844,
      "2024-06-28T15:30:00+00:00": 169.5749969482422,
      "2024-06-28T16:30:00+00:00": 169.57000732421875,
      "2024-06-28T17:30:00+00:00": 169.6999969482422,
      "2024-06-28T18:30:00+00:00": 170.1999969482422,
      "2024-06-28T19:30:00+00:00": 170.02999877929688
    },
    "sentiment": 0.9470972418785095
  },
  {
    "title": "FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma",
    "published": 1719500580,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 171.2899932861328,
      "2024-06-27T14:30:00+00:00": 170.1699981689453,
      "2024-06-27T15:30:00+00:00": 169.25999450683594,
      "2024-06-27T16:30:00+00:00": 168.36000061035156,
      "2024-06-27T17:30:00+00:00": 168.50990295410156,
      "2024-06-27T18:30:00+00:00": 168.44000244140625,
      "2024-06-27T19:30:00+00:00": 169.0399932861328
    },
    "sentiment": 0.9441196918487549
  },
  {
    "title": "Merck's (MRK) Lung Cancer Candidate Faces FDA Rejection",
    "published": 1719498060,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 171.2899932861328,
      "2024-06-27T14:30:00+00:00": 170.1699981689453,
      "2024-06-27T15:30:00+00:00": 169.25999450683594,
      "2024-06-27T16:30:00+00:00": 168.36000061035156,
      "2024-06-27T17:30:00+00:00": 168.50990295410156,
      "2024-06-27T18:30:00+00:00": 168.44000244140625,
      "2024-06-27T19:30:00+00:00": 169.0399932861328
    },
    "sentiment": 0.8310019969940186
  },
  {
    "title": "AbbVie Acquires Celsius Therapeutics",
    "published": 1719494760,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 171.2899932861328,
      "2024-06-27T14:30:00+00:00": 170.1699981689453,
      "2024-06-27T15:30:00+00:00": 169.25999450683594,
      "2024-06-27T16:30:00+00:00": 168.36000061035156,
      "2024-06-27T17:30:00+00:00": 168.50990295410156,
      "2024-06-27T18:30:00+00:00": 168.44000244140625,
      "2024-06-27T19:30:00+00:00": 169.0399932861328
    },
    "sentiment": 0.9040334820747375
  },
  {
    "title": "Cerevel Therapeutics gains on report Tempur Sealy will be the subject of FTC meeting",
    "published": 1719492300,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 171.2899932861328,
      "2024-06-27T14:30:00+00:00": 170.1699981689453,
      "2024-06-27T15:30:00+00:00": 169.25999450683594,
      "2024-06-27T16:30:00+00:00": 168.36000061035156,
      "2024-06-27T17:30:00+00:00": 168.50990295410156,
      "2024-06-27T18:30:00+00:00": 168.44000244140625,
      "2024-06-27T19:30:00+00:00": 169.0399932861328
    },
    "sentiment": 0.8790897130966187
  },
  {
    "title": "AbbVie/Genmab's Epkinly FDA Approval Is A Positive Step, Analyst Says Additional Expansion Opportunities Underway",
    "published": 1719491160,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 171.2899932861328,
      "2024-06-27T14:30:00+00:00": 170.1699981689453,
      "2024-06-27T15:30:00+00:00": 169.25999450683594,
      "2024-06-27T16:30:00+00:00": 168.36000061035156,
      "2024-06-27T17:30:00+00:00": 168.50990295410156,
      "2024-06-27T18:30:00+00:00": 168.44000244140625,
      "2024-06-27T19:30:00+00:00": 169.0399932861328
    },
    "sentiment": 0.9408528208732605
  },
  {
    "title": "Looking At AbbVie's Recent Unusual Options Activity",
    "published": 1719486540,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 171.2899932861328,
      "2024-06-27T14:30:00+00:00": 170.1699981689453,
      "2024-06-27T15:30:00+00:00": 169.25999450683594,
      "2024-06-27T16:30:00+00:00": 168.36000061035156,
      "2024-06-27T17:30:00+00:00": 168.50990295410156,
      "2024-06-27T18:30:00+00:00": 168.44000244140625,
      "2024-06-27T19:30:00+00:00": 169.0399932861328
    },
    "sentiment": 0.8851532340049744
  },
  {
    "title": "AbbVie expands its IBD prospects with $250M Celsius deal",
    "published": 1719483759,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 171.2899932861328,
      "2024-06-27T14:30:00+00:00": 170.1699981689453,
      "2024-06-27T15:30:00+00:00": 169.25999450683594,
      "2024-06-27T16:30:00+00:00": 168.36000061035156,
      "2024-06-27T17:30:00+00:00": 168.50990295410156,
      "2024-06-27T18:30:00+00:00": 168.44000244140625,
      "2024-06-27T19:30:00+00:00": 169.0399932861328
    },
    "sentiment": 0.8766075372695923
  },
  {
    "title": "Can AbbVie Stock Keep Outpacing the S&P 500?",
    "published": 1719480600,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 171.2899932861328,
      "2024-06-27T14:30:00+00:00": 170.1699981689453,
      "2024-06-27T15:30:00+00:00": 169.25999450683594,
      "2024-06-27T16:30:00+00:00": 168.36000061035156,
      "2024-06-27T17:30:00+00:00": 168.50990295410156,
      "2024-06-27T18:30:00+00:00": 168.44000244140625,
      "2024-06-27T19:30:00+00:00": 169.0399932861328
    },
    "sentiment": 0.7975728511810303
  },
  {
    "title": "AbbVie gains FDA approval for EPKINLY in follicular lymphoma",
    "published": 1719477154,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 171.2899932861328,
      "2024-06-27T14:30:00+00:00": 170.1699981689453,
      "2024-06-27T15:30:00+00:00": 169.25999450683594,
      "2024-06-27T16:30:00+00:00": 168.36000061035156,
      "2024-06-27T17:30:00+00:00": 168.50990295410156,
      "2024-06-27T18:30:00+00:00": 168.44000244140625,
      "2024-06-27T19:30:00+00:00": 169.0399932861328
    },
    "sentiment": 0.948319673538208
  },
  {
    "title": "AbbVie acquires Celsius Therapeutics for $250M in cash",
    "published": 1719476940,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 171.2899932861328,
      "2024-06-27T14:30:00+00:00": 170.1699981689453,
      "2024-06-27T15:30:00+00:00": 169.25999450683594,
      "2024-06-27T16:30:00+00:00": 168.36000061035156,
      "2024-06-27T17:30:00+00:00": 168.50990295410156,
      "2024-06-27T18:30:00+00:00": 168.44000244140625,
      "2024-06-27T19:30:00+00:00": 169.0399932861328
    },
    "sentiment": 0.9140102863311768
  },
  {
    "title": "Genmab, AbbVie win FDA nod for r/r follicular lymphoma therapy",
    "published": 1719463200,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 171.2899932861328,
      "2024-06-27T14:30:00+00:00": 170.1699981689453,
      "2024-06-27T15:30:00+00:00": 169.25999450683594,
      "2024-06-27T16:30:00+00:00": 168.36000061035156,
      "2024-06-27T17:30:00+00:00": 168.50990295410156,
      "2024-06-27T18:30:00+00:00": 168.44000244140625,
      "2024-06-27T19:30:00+00:00": 169.0399932861328
    },
    "sentiment": 0.9165933132171631
  },
  {
    "title": "Coherus to divest biosimilar against AbbVie\u2019s Humira for $40M",
    "published": 1719450540,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 171.2899932861328,
      "2024-06-27T14:30:00+00:00": 170.1699981689453,
      "2024-06-27T15:30:00+00:00": 169.25999450683594,
      "2024-06-27T16:30:00+00:00": 168.36000061035156,
      "2024-06-27T17:30:00+00:00": 168.50990295410156,
      "2024-06-27T18:30:00+00:00": 168.44000244140625,
      "2024-06-27T19:30:00+00:00": 169.0399932861328
    },
    "sentiment": 0.8612374663352966
  },
  {
    "title": "GLOBAL BRIEFING: European stock called lower ahead of US GDP data",
    "published": 1719448080,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 171.2899932861328,
      "2024-06-27T14:30:00+00:00": 170.1699981689453,
      "2024-06-27T15:30:00+00:00": 169.25999450683594,
      "2024-06-27T16:30:00+00:00": 168.36000061035156,
      "2024-06-27T17:30:00+00:00": 168.50990295410156,
      "2024-06-27T18:30:00+00:00": 168.44000244140625,
      "2024-06-27T19:30:00+00:00": 169.0399932861328
    },
    "sentiment": 0.9622932076454163
  },
  {
    "title": "U.S. Food and Drug Administration Grants Second Approval for AbbVie's EPKINLY (epcoritamab-bysp) to Treat Patients with Relapsed or Refractory Follicular Lymphoma",
    "published": 1719428580,
    "day_prices": {
      "2024-06-26T13:30:00+00:00": 170.2899932861328,
      "2024-06-26T14:30:00+00:00": 170.57749938964844,
      "2024-06-26T15:30:00+00:00": 171.19000244140625,
      "2024-06-26T16:30:00+00:00": 171.7899932861328,
      "2024-06-26T17:30:00+00:00": 171.77000427246094,
      "2024-06-26T18:30:00+00:00": 172.00999450683594,
      "2024-06-26T19:30:00+00:00": 172.11500549316406
    },
    "sentiment": 0.9348030090332031
  },
  {
    "title": "AbbVie (ABBV) Parkinson's Candidate Faces 2nd FDA Rejection",
    "published": 1719407100,
    "day_prices": {
      "2024-06-26T13:30:00+00:00": 170.2899932861328,
      "2024-06-26T14:30:00+00:00": 170.57749938964844,
      "2024-06-26T15:30:00+00:00": 171.19000244140625,
      "2024-06-26T16:30:00+00:00": 171.7899932861328,
      "2024-06-26T17:30:00+00:00": 171.77000427246094,
      "2024-06-26T18:30:00+00:00": 172.00999450683594,
      "2024-06-26T19:30:00+00:00": 172.11500549316406
    },
    "sentiment": 0.8371016979217529
  },
  {
    "title": "Zealand hauls in $1B off obesity drug data; Curie.bio zeroes in on Series A\u2019s",
    "published": 1719399600,
    "day_prices": {
      "2024-06-26T13:30:00+00:00": 170.2899932861328,
      "2024-06-26T14:30:00+00:00": 170.57749938964844,
      "2024-06-26T15:30:00+00:00": 171.19000244140625,
      "2024-06-26T16:30:00+00:00": 171.7899932861328,
      "2024-06-26T17:30:00+00:00": 171.77000427246094,
      "2024-06-26T18:30:00+00:00": 172.00999450683594,
      "2024-06-26T19:30:00+00:00": 172.11500549316406
    },
    "sentiment": 0.4785342514514923
  },
  {
    "title": "AbbVie Provides U.S. Regulatory Update on ABBV-951",
    "published": 1719392306,
    "day_prices": {
      "2024-06-26T13:30:00+00:00": 170.2899932861328,
      "2024-06-26T14:30:00+00:00": 170.57749938964844,
      "2024-06-26T15:30:00+00:00": 171.19000244140625,
      "2024-06-26T16:30:00+00:00": 171.7899932861328,
      "2024-06-26T17:30:00+00:00": 171.77000427246094,
      "2024-06-26T18:30:00+00:00": 172.00999450683594,
      "2024-06-26T19:30:00+00:00": 172.11500549316406
    },
    "sentiment": 0.9373561143875122
  },
  {
    "title": "FDA grands second approval for AbbVie's EPKINLY in follicular lymphoma Genmab",
    "published": 1719382140,
    "day_prices": {
      "2024-06-26T13:30:00+00:00": 170.2899932861328,
      "2024-06-26T14:30:00+00:00": 170.57749938964844,
      "2024-06-26T15:30:00+00:00": 171.19000244140625,
      "2024-06-26T16:30:00+00:00": 171.7899932861328,
      "2024-06-26T17:30:00+00:00": 171.77000427246094,
      "2024-06-26T18:30:00+00:00": 172.00999450683594,
      "2024-06-26T19:30:00+00:00": 172.11500549316406
    },
    "sentiment": 0.7915589809417725
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (TEVA), AbbVie (ABBV) and Insmed (INSM)",
    "published": 1719367980,
    "day_prices": {
      "2024-06-26T13:30:00+00:00": 170.2899932861328,
      "2024-06-26T14:30:00+00:00": 170.57749938964844,
      "2024-06-26T15:30:00+00:00": 171.19000244140625,
      "2024-06-26T16:30:00+00:00": 171.7899932861328,
      "2024-06-26T17:30:00+00:00": 171.77000427246094,
      "2024-06-26T18:30:00+00:00": 172.00999450683594,
      "2024-06-26T19:30:00+00:00": 172.11500549316406
    },
    "sentiment": 0.9330945014953613
  },
  {
    "title": "IN BRIEF: AbbVie Parkinson's drug not approved in present form",
    "published": 1719329340,
    "day_prices": {
      "2024-06-25T13:30:00+00:00": 171.98500061035156,
      "2024-06-25T14:30:00+00:00": 172.52000427246094,
      "2024-06-25T15:30:00+00:00": 171.49000549316406,
      "2024-06-25T16:30:00+00:00": 171.11500549316406,
      "2024-06-25T17:30:00+00:00": 171.5800018310547,
      "2024-06-25T18:30:00+00:00": 171.42999267578125,
      "2024-06-25T19:30:00+00:00": 171.02999877929688
    },
    "sentiment": 0.8964545130729675
  },
  {
    "title": "AbbVie Provides U.S. Regulatory Update on ABBV-951 (Foscarbidopa/Foslevodopa)",
    "published": 1719317700,
    "day_prices": {
      "2024-06-25T13:30:00+00:00": 171.98500061035156,
      "2024-06-25T14:30:00+00:00": 172.52000427246094,
      "2024-06-25T15:30:00+00:00": 171.49000549316406,
      "2024-06-25T16:30:00+00:00": 171.11500549316406,
      "2024-06-25T17:30:00+00:00": 171.5800018310547,
      "2024-06-25T18:30:00+00:00": 171.42999267578125,
      "2024-06-25T19:30:00+00:00": 171.02999877929688
    },
    "sentiment": 0.9348647594451904
  },
  {
    "title": "FDA snubs AbbVie Parkinson's combo",
    "published": 1719304320,
    "day_prices": {
      "2024-06-25T13:30:00+00:00": 171.98500061035156,
      "2024-06-25T14:30:00+00:00": 172.52000427246094,
      "2024-06-25T15:30:00+00:00": 171.49000549316406,
      "2024-06-25T16:30:00+00:00": 171.11500549316406,
      "2024-06-25T17:30:00+00:00": 171.5800018310547,
      "2024-06-25T18:30:00+00:00": 171.42999267578125,
      "2024-06-25T19:30:00+00:00": 171.02999877929688
    },
    "sentiment": 0.7432487607002258
  },
  {
    "title": "From Sci-Fi Dream to Market Maze: Eli Lilly's Weight-Loss Medication Faces Hurdles",
    "published": 1719302460,
    "day_prices": {
      "2024-06-25T13:30:00+00:00": 171.98500061035156,
      "2024-06-25T14:30:00+00:00": 172.52000427246094,
      "2024-06-25T15:30:00+00:00": 171.49000549316406,
      "2024-06-25T16:30:00+00:00": 171.11500549316406,
      "2024-06-25T17:30:00+00:00": 171.5800018310547,
      "2024-06-25T18:30:00+00:00": 171.42999267578125,
      "2024-06-25T19:30:00+00:00": 171.02999877929688
    },
    "sentiment": 0.9066510796546936
  },
  {
    "title": "Cerevel Therapeutics sinks amid some worry on FTC review of AbbVie deal",
    "published": 1719281580,
    "day_prices": {
      "2024-06-25T13:30:00+00:00": 171.98500061035156,
      "2024-06-25T14:30:00+00:00": 172.52000427246094,
      "2024-06-25T15:30:00+00:00": 171.49000549316406,
      "2024-06-25T16:30:00+00:00": 171.11500549316406,
      "2024-06-25T17:30:00+00:00": 171.5800018310547,
      "2024-06-25T18:30:00+00:00": 171.42999267578125,
      "2024-06-25T19:30:00+00:00": 171.02999877929688
    },
    "sentiment": 0.8795490860939026
  },
  {
    "title": "If You Invested $1000 in AbbVie a Decade Ago, This is How Much It'd Be Worth Now",
    "published": 1719232202,
    "day_prices": {
      "2024-06-24T13:30:00+00:00": 171.1300048828125,
      "2024-06-24T14:30:00+00:00": 172.92999267578125,
      "2024-06-24T15:30:00+00:00": 172.24000549316406,
      "2024-06-24T16:30:00+00:00": 172.93499755859375,
      "2024-06-24T17:30:00+00:00": 172.5399932861328,
      "2024-06-24T18:30:00+00:00": 173.08999633789062,
      "2024-06-24T19:30:00+00:00": 172.77000427246094
    },
    "sentiment": 0.9186922311782837
  },
  {
    "title": "Week In Review: FutureGen Sells mAb For IBD To AbbVie In $1.7 Billion Deal",
    "published": 1719218400,
    "day_prices": {
      "2024-06-24T13:30:00+00:00": 171.1300048828125,
      "2024-06-24T14:30:00+00:00": 172.92999267578125,
      "2024-06-24T15:30:00+00:00": 172.24000549316406,
      "2024-06-24T16:30:00+00:00": 172.93499755859375,
      "2024-06-24T17:30:00+00:00": 172.5399932861328,
      "2024-06-24T18:30:00+00:00": 173.08999633789062,
      "2024-06-24T19:30:00+00:00": 172.77000427246094
    },
    "sentiment": 0.9354187250137329
  },
  {
    "title": "Add portfolio diversity with these BMO value stock picks",
    "published": 1719143400,
    "day_prices": {},
    "sentiment": 0.755445122718811
  },
  {
    "title": "AbbVie Inc. Dividend Stock Analysis - Saturday, June 22",
    "published": 1719024000,
    "day_prices": {},
    "sentiment": 0.910502016544342
  },
  {
    "title": "Pharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs",
    "published": 1718977500,
    "day_prices": {
      "2024-06-21T13:30:00+00:00": 172.6999969482422,
      "2024-06-21T14:30:00+00:00": 171.48159790039062,
      "2024-06-21T15:30:00+00:00": 170.3699951171875,
      "2024-06-21T16:30:00+00:00": 170.6300048828125,
      "2024-06-21T17:30:00+00:00": 170.1199951171875,
      "2024-06-21T18:30:00+00:00": 170.1300048828125,
      "2024-06-21T19:30:00+00:00": 170.75990295410156
    },
    "sentiment": 0.8707846403121948
  },
  {
    "title": "Check Out What Whales Are Doing With ABBV",
    "published": 1718936640,
    "day_prices": {
      "2024-06-21T13:30:00+00:00": 172.6999969482422,
      "2024-06-21T14:30:00+00:00": 171.48159790039062,
      "2024-06-21T15:30:00+00:00": 170.3699951171875,
      "2024-06-21T16:30:00+00:00": 170.6300048828125,
      "2024-06-21T17:30:00+00:00": 170.1199951171875,
      "2024-06-21T18:30:00+00:00": 170.1300048828125,
      "2024-06-21T19:30:00+00:00": 170.75990295410156
    },
    "sentiment": 0.9342471361160278
  },
  {
    "title": "3 Biotech Stocks to Buy Now: June 2024",
    "published": 1718931780,
    "day_prices": {
      "2024-06-21T13:30:00+00:00": 172.6999969482422,
      "2024-06-21T14:30:00+00:00": 171.48159790039062,
      "2024-06-21T15:30:00+00:00": 170.3699951171875,
      "2024-06-21T16:30:00+00:00": 170.6300048828125,
      "2024-06-21T17:30:00+00:00": 170.1199951171875,
      "2024-06-21T18:30:00+00:00": 170.1300048828125,
      "2024-06-21T19:30:00+00:00": 170.75990295410156
    },
    "sentiment": 0.9347099661827087
  },
  {
    "title": "Revance Therapeutics: Problems Mounting Amid Legal And Financial Woes",
    "published": 1718901655,
    "day_prices": {
      "2024-06-20T13:30:00+00:00": 171.17999267578125,
      "2024-06-20T14:30:00+00:00": 171.25999450683594,
      "2024-06-20T15:30:00+00:00": 171.47000122070312,
      "2024-06-20T16:30:00+00:00": 172.36500549316406,
      "2024-06-20T17:30:00+00:00": 172.41000366210938,
      "2024-06-20T18:30:00+00:00": 172.7050018310547,
      "2024-06-20T19:30:00+00:00": 172.6999969482422
    },
    "sentiment": 0.961752712726593
  },
  {
    "title": "Wall Street Favorites: 3 Retirement Stocks With Strong Buy Ratings for June 2024",
    "published": 1718888400,
    "day_prices": {
      "2024-06-20T13:30:00+00:00": 171.17999267578125,
      "2024-06-20T14:30:00+00:00": 171.25999450683594,
      "2024-06-20T15:30:00+00:00": 171.47000122070312,
      "2024-06-20T16:30:00+00:00": 172.36500549316406,
      "2024-06-20T17:30:00+00:00": 172.41000366210938,
      "2024-06-20T18:30:00+00:00": 172.7050018310547,
      "2024-06-20T19:30:00+00:00": 172.6999969482422
    },
    "sentiment": 0.574688196182251
  },
  {
    "title": "AbbVie Stock Price Forecast: $200 On The Cards?",
    "published": 1718886840,
    "day_prices": {
      "2024-06-20T13:30:00+00:00": 171.17999267578125,
      "2024-06-20T14:30:00+00:00": 171.25999450683594,
      "2024-06-20T15:30:00+00:00": 171.47000122070312,
      "2024-06-20T16:30:00+00:00": 172.36500549316406,
      "2024-06-20T17:30:00+00:00": 172.41000366210938,
      "2024-06-20T18:30:00+00:00": 172.7050018310547,
      "2024-06-20T19:30:00+00:00": 172.6999969482422
    },
    "sentiment": 0.9293221235275269
  },
  {
    "title": "US FDA proposes to remove switching study requirement for biosimilars",
    "published": 1718884648,
    "day_prices": {
      "2024-06-20T13:30:00+00:00": 171.17999267578125,
      "2024-06-20T14:30:00+00:00": 171.25999450683594,
      "2024-06-20T15:30:00+00:00": 171.47000122070312,
      "2024-06-20T16:30:00+00:00": 172.36500549316406,
      "2024-06-20T17:30:00+00:00": 172.41000366210938,
      "2024-06-20T18:30:00+00:00": 172.7050018310547,
      "2024-06-20T19:30:00+00:00": 172.6999969482422
    },
    "sentiment": 0.6590848565101624
  },
  {
    "title": "AbbVie (ABBV) Gets a Buy from Cantor Fitzgerald",
    "published": 1718882760,
    "day_prices": {
      "2024-06-20T13:30:00+00:00": 171.17999267578125,
      "2024-06-20T14:30:00+00:00": 171.25999450683594,
      "2024-06-20T15:30:00+00:00": 171.47000122070312,
      "2024-06-20T16:30:00+00:00": 172.36500549316406,
      "2024-06-20T17:30:00+00:00": 172.41000366210938,
      "2024-06-20T18:30:00+00:00": 172.7050018310547,
      "2024-06-20T19:30:00+00:00": 172.6999969482422
    },
    "sentiment": 0.8193525671958923
  },
  {
    "title": "AbbVie names Roxanne Austin as lead independent director",
    "published": 1718867340,
    "day_prices": {
      "2024-06-20T13:30:00+00:00": 171.17999267578125,
      "2024-06-20T14:30:00+00:00": 171.25999450683594,
      "2024-06-20T15:30:00+00:00": 171.47000122070312,
      "2024-06-20T16:30:00+00:00": 172.36500549316406,
      "2024-06-20T17:30:00+00:00": 172.41000366210938,
      "2024-06-20T18:30:00+00:00": 172.7050018310547,
      "2024-06-20T19:30:00+00:00": 172.6999969482422
    },
    "sentiment": 0.9416839480400085
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Korro Bio (KRRO), AbbVie (ABBV) and Emergent Biosolutions (EBS)",
    "published": 1718863860,
    "day_prices": {
      "2024-06-20T13:30:00+00:00": 171.17999267578125,
      "2024-06-20T14:30:00+00:00": 171.25999450683594,
      "2024-06-20T15:30:00+00:00": 171.47000122070312,
      "2024-06-20T16:30:00+00:00": 172.36500549316406,
      "2024-06-20T17:30:00+00:00": 172.41000366210938,
      "2024-06-20T18:30:00+00:00": 172.7050018310547,
      "2024-06-20T19:30:00+00:00": 172.6999969482422
    },
    "sentiment": 0.8893043398857117
  },
  {
    "title": "AbbVie wins FDA nod for new Skyrizi indication",
    "published": 1718862240,
    "day_prices": {
      "2024-06-20T13:30:00+00:00": 171.17999267578125,
      "2024-06-20T14:30:00+00:00": 171.25999450683594,
      "2024-06-20T15:30:00+00:00": 171.47000122070312,
      "2024-06-20T16:30:00+00:00": 172.36500549316406,
      "2024-06-20T17:30:00+00:00": 172.41000366210938,
      "2024-06-20T18:30:00+00:00": 172.7050018310547,
      "2024-06-20T19:30:00+00:00": 172.6999969482422
    },
    "sentiment": 0.8854588866233826
  },
  {
    "title": "Why AbbVie (ABBV) is a Great Dividend Stock Right Now",
    "published": 1718811908,
    "day_prices": {},
    "sentiment": 0.8425612449645996
  },
  {
    "title": "AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis",
    "published": 1718801100,
    "day_prices": {},
    "sentiment": 0.8832394480705261
  },
  {
    "title": "Bert's May Dividend Income Summary (2024 Edition)",
    "published": 1718798340,
    "day_prices": {},
    "sentiment": 0.9133232235908508
  },
  {
    "title": "AbbVie\u2019s SKYRIZI gains US FDA approval for ulcerative colitis",
    "published": 1718784735,
    "day_prices": {},
    "sentiment": 0.9477657079696655
  },
  {
    "title": "AbbVie: FDA approval in ulcerative colitis",
    "published": 1718763557,
    "day_prices": {},
    "sentiment": 0.8275504112243652
  },
  {
    "title": "Earn Income While Playing The Hottest Sectors",
    "published": 1718759580,
    "day_prices": {},
    "sentiment": 0.9102174639701843
  },
  {
    "title": "AbbVie (ABBV) Exceeds Market Returns: Some Facts to Consider",
    "published": 1718747119,
    "day_prices": {
      "2024-06-18T13:30:00+00:00": 170.44000244140625,
      "2024-06-18T14:30:00+00:00": 172.86000061035156,
      "2024-06-18T15:30:00+00:00": 172.38999938964844,
      "2024-06-18T16:30:00+00:00": 171.57000732421875,
      "2024-06-18T17:30:00+00:00": 171.13999938964844,
      "2024-06-18T18:30:00+00:00": 171.3800048828125,
      "2024-06-18T19:30:00+00:00": 171.625
    },
    "sentiment": 0.9312770962715149
  },
  {
    "title": "Intra-Cellular Therapies edges closer to FDA win for Caplyta in depression",
    "published": 1718732079,
    "day_prices": {
      "2024-06-18T13:30:00+00:00": 170.44000244140625,
      "2024-06-18T14:30:00+00:00": 172.86000061035156,
      "2024-06-18T15:30:00+00:00": 172.38999938964844,
      "2024-06-18T16:30:00+00:00": 171.57000732421875,
      "2024-06-18T17:30:00+00:00": 171.13999938964844,
      "2024-06-18T18:30:00+00:00": 171.3800048828125,
      "2024-06-18T19:30:00+00:00": 171.625
    },
    "sentiment": 0.8989197611808777
  },
  {
    "title": "Humira: the highs and lows of the world\u2019s best-selling drug",
    "published": 1718705586,
    "day_prices": {
      "2024-06-18T13:30:00+00:00": 170.44000244140625,
      "2024-06-18T14:30:00+00:00": 172.86000061035156,
      "2024-06-18T15:30:00+00:00": 172.38999938964844,
      "2024-06-18T16:30:00+00:00": 171.57000732421875,
      "2024-06-18T17:30:00+00:00": 171.13999938964844,
      "2024-06-18T18:30:00+00:00": 171.3800048828125,
      "2024-06-18T19:30:00+00:00": 171.625
    },
    "sentiment": 0.6293830275535583
  },
  {
    "title": "Analysts\u2019 Top Healthcare Picks: Merit Medical Systems (MMSI), AbbVie (ABBV)",
    "published": 1718690460,
    "day_prices": {
      "2024-06-18T13:30:00+00:00": 170.44000244140625,
      "2024-06-18T14:30:00+00:00": 172.86000061035156,
      "2024-06-18T15:30:00+00:00": 172.38999938964844,
      "2024-06-18T16:30:00+00:00": 171.57000732421875,
      "2024-06-18T17:30:00+00:00": 171.13999938964844,
      "2024-06-18T18:30:00+00:00": 171.3800048828125,
      "2024-06-18T19:30:00+00:00": 171.625
    },
    "sentiment": 0.7667814493179321
  },
  {
    "title": "AbbVie: FDA approves SKYRIZI for ulcerative colitis",
    "published": 1718688120,
    "day_prices": {
      "2024-06-18T13:30:00+00:00": 170.44000244140625,
      "2024-06-18T14:30:00+00:00": 172.86000061035156,
      "2024-06-18T15:30:00+00:00": 172.38999938964844,
      "2024-06-18T16:30:00+00:00": 171.57000732421875,
      "2024-06-18T17:30:00+00:00": 171.13999938964844,
      "2024-06-18T18:30:00+00:00": 171.3800048828125,
      "2024-06-18T19:30:00+00:00": 171.625
    },
    "sentiment": 0.7887654900550842
  },
  {
    "title": "Amgen: You Haven't Seen Anything Yet",
    "published": 1718623803,
    "day_prices": {
      "2024-06-17T13:30:00+00:00": 168.39999389648438,
      "2024-06-17T14:30:00+00:00": 169.5399932861328,
      "2024-06-17T15:30:00+00:00": 169.24000549316406,
      "2024-06-17T16:30:00+00:00": 169.52499389648438,
      "2024-06-17T17:30:00+00:00": 169.22000122070312,
      "2024-06-17T18:30:00+00:00": 169.66000366210938,
      "2024-06-17T19:30:00+00:00": 169.66000366210938
    },
    "sentiment": 0.8896852135658264
  },
  {
    "title": "2 Dividend Stocks That Could Pay You for Life",
    "published": 1718541000,
    "day_prices": {},
    "sentiment": 0.9197719693183899
  },
  {
    "title": "ALS therapy market seen increasing to nearly $1.3B by 2029",
    "published": 1718419260,
    "day_prices": {},
    "sentiment": 0.8988731503486633
  },
  {
    "title": "Disc Medicine: Hematological Disorders Treatment Advances With DISC-0974 Progress",
    "published": 1718371607,
    "day_prices": {
      "2024-06-14T13:30:00+00:00": 166.47000122070312,
      "2024-06-14T14:30:00+00:00": 166.7100067138672,
      "2024-06-14T15:30:00+00:00": 168.26499938964844,
      "2024-06-14T16:30:00+00:00": 168.7100067138672,
      "2024-06-14T17:30:00+00:00": 168.11000061035156,
      "2024-06-14T18:30:00+00:00": 168.61000061035156,
      "2024-06-14T19:30:00+00:00": 169.1999969482422
    },
    "sentiment": 0.8615251779556274
  },
  {
    "title": "AbbVie (ABBV) Buys Global Rights to Novel IBD Candidate",
    "published": 1718369400,
    "day_prices": {
      "2024-06-14T13:30:00+00:00": 166.47000122070312,
      "2024-06-14T14:30:00+00:00": 166.7100067138672,
      "2024-06-14T15:30:00+00:00": 168.26499938964844,
      "2024-06-14T16:30:00+00:00": 168.7100067138672,
      "2024-06-14T17:30:00+00:00": 168.11000061035156,
      "2024-06-14T18:30:00+00:00": 168.61000061035156,
      "2024-06-14T19:30:00+00:00": 169.1999969482422
    },
    "sentiment": 0.8585211634635925
  },
  {
    "title": "The Dividend Defenders: 3 Stocks That Will Protect and Grow Your Wealth Dividend Stocks",
    "published": 1718360100,
    "day_prices": {
      "2024-06-14T13:30:00+00:00": 166.47000122070312,
      "2024-06-14T14:30:00+00:00": 166.7100067138672,
      "2024-06-14T15:30:00+00:00": 168.26499938964844,
      "2024-06-14T16:30:00+00:00": 168.7100067138672,
      "2024-06-14T17:30:00+00:00": 168.11000061035156,
      "2024-06-14T18:30:00+00:00": 168.61000061035156,
      "2024-06-14T19:30:00+00:00": 169.1999969482422
    },
    "sentiment": 0.8916819095611572
  },
  {
    "title": "7 A-Rated Biotech Stocks Worth Betting on in June",
    "published": 1718345760,
    "day_prices": {
      "2024-06-14T13:30:00+00:00": 166.47000122070312,
      "2024-06-14T14:30:00+00:00": 166.7100067138672,
      "2024-06-14T15:30:00+00:00": 168.26499938964844,
      "2024-06-14T16:30:00+00:00": 168.7100067138672,
      "2024-06-14T17:30:00+00:00": 168.11000061035156,
      "2024-06-14T18:30:00+00:00": 168.61000061035156,
      "2024-06-14T19:30:00+00:00": 169.1999969482422
    },
    "sentiment": 0.8425544500350952
  },
  {
    "title": "Hold Rating Maintained for AbbVie Amidst Revenue Erosion and Strategic Uncertainties",
    "published": 1718339160,
    "day_prices": {
      "2024-06-14T13:30:00+00:00": 166.47000122070312,
      "2024-06-14T14:30:00+00:00": 166.7100067138672,
      "2024-06-14T15:30:00+00:00": 168.26499938964844,
      "2024-06-14T16:30:00+00:00": 168.7100067138672,
      "2024-06-14T17:30:00+00:00": 168.11000061035156,
      "2024-06-14T18:30:00+00:00": 168.61000061035156,
      "2024-06-14T19:30:00+00:00": 169.1999969482422
    },
    "sentiment": 0.8115677237510681
  },
  {
    "title": "AbbVie recommends shareholders reject Tutanota's 'mini-tender' offer",
    "published": 1718334600,
    "day_prices": {
      "2024-06-14T13:30:00+00:00": 166.47000122070312,
      "2024-06-14T14:30:00+00:00": 166.7100067138672,
      "2024-06-14T15:30:00+00:00": 168.26499938964844,
      "2024-06-14T16:30:00+00:00": 168.7100067138672,
      "2024-06-14T17:30:00+00:00": 168.11000061035156,
      "2024-06-14T18:30:00+00:00": 168.61000061035156,
      "2024-06-14T19:30:00+00:00": 169.1999969482422
    },
    "sentiment": 0.8502224087715149
  },
  {
    "title": "Here's How Many Shares Of AbbVie You Would Need To Earn $500 Per Month In Dividends",
    "published": 1718294443,
    "day_prices": {
      "2024-06-13T13:30:00+00:00": 166.0,
      "2024-06-13T14:30:00+00:00": 166.10830688476562,
      "2024-06-13T15:30:00+00:00": 166.7949981689453,
      "2024-06-13T16:30:00+00:00": 166.36000061035156,
      "2024-06-13T17:30:00+00:00": 166.65750122070312,
      "2024-06-13T18:30:00+00:00": 166.28500366210938,
      "2024-06-13T19:30:00+00:00": 166.47000122070312
    },
    "sentiment": 0.945155680179596
  },
  {
    "title": "Cerevel Therapeutics seesaws amid FTC notice on closed door meeting",
    "published": 1718283540,
    "day_prices": {
      "2024-06-13T13:30:00+00:00": 166.0,
      "2024-06-13T14:30:00+00:00": 166.10830688476562,
      "2024-06-13T15:30:00+00:00": 166.7949981689453,
      "2024-06-13T16:30:00+00:00": 166.36000061035156,
      "2024-06-13T17:30:00+00:00": 166.65750122070312,
      "2024-06-13T18:30:00+00:00": 166.28500366210938,
      "2024-06-13T19:30:00+00:00": 166.47000122070312
    },
    "sentiment": 0.9429758191108704
  },
  {
    "title": "AbbVie, FutureGen in License Pact for Inflammatory Bowel Disease Drug",
    "published": 1718270356,
    "day_prices": {
      "2024-06-13T13:30:00+00:00": 166.0,
      "2024-06-13T14:30:00+00:00": 166.10830688476562,
      "2024-06-13T15:30:00+00:00": 166.7949981689453,
      "2024-06-13T16:30:00+00:00": 166.36000061035156,
      "2024-06-13T17:30:00+00:00": 166.65750122070312,
      "2024-06-13T18:30:00+00:00": 166.28500366210938,
      "2024-06-13T19:30:00+00:00": 166.47000122070312
    },
    "sentiment": 0.7712298035621643
  },
  {
    "title": "AbbVie inks licensing pact for bowel disorder therapy",
    "published": 1718263740,
    "day_prices": {
      "2024-06-13T13:30:00+00:00": 166.0,
      "2024-06-13T14:30:00+00:00": 166.10830688476562,
      "2024-06-13T15:30:00+00:00": 166.7949981689453,
      "2024-06-13T16:30:00+00:00": 166.36000061035156,
      "2024-06-13T17:30:00+00:00": 166.65750122070312,
      "2024-06-13T18:30:00+00:00": 166.28500366210938,
      "2024-06-13T19:30:00+00:00": 166.47000122070312
    },
    "sentiment": 0.8740696310997009
  },
  {
    "title": "Analysts Are Bullish on Top Healthcare Stocks: Perspective Therapeutics (CATX), AbbVie (ABBV)",
    "published": 1718258640,
    "day_prices": {
      "2024-06-13T13:30:00+00:00": 166.0,
      "2024-06-13T14:30:00+00:00": 166.10830688476562,
      "2024-06-13T15:30:00+00:00": 166.7949981689453,
      "2024-06-13T16:30:00+00:00": 166.36000061035156,
      "2024-06-13T17:30:00+00:00": 166.65750122070312,
      "2024-06-13T18:30:00+00:00": 166.28500366210938,
      "2024-06-13T19:30:00+00:00": 166.47000122070312
    },
    "sentiment": 0.7197863459587097
  },
  {
    "title": "AbbVie, Inc. (ABBV) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)",
    "published": 1718219527,
    "day_prices": {
      "2024-06-12T13:30:00+00:00": 168.0,
      "2024-06-12T14:30:00+00:00": 165.6199951171875,
      "2024-06-12T15:30:00+00:00": 165.47000122070312,
      "2024-06-12T16:30:00+00:00": 165.6199951171875,
      "2024-06-12T17:30:00+00:00": 165.89500427246094,
      "2024-06-12T18:30:00+00:00": 165.3300018310547,
      "2024-06-12T19:30:00+00:00": 165.72999572753906
    },
    "sentiment": 0.9286439418792725
  },
  {
    "title": "Cerevel Therapeutics gains after AbbVie says making good progress with FTC",
    "published": 1718188560,
    "day_prices": {
      "2024-06-12T13:30:00+00:00": 168.0,
      "2024-06-12T14:30:00+00:00": 165.6199951171875,
      "2024-06-12T15:30:00+00:00": 165.47000122070312,
      "2024-06-12T16:30:00+00:00": 165.6199951171875,
      "2024-06-12T17:30:00+00:00": 165.89500427246094,
      "2024-06-12T18:30:00+00:00": 165.3300018310547,
      "2024-06-12T19:30:00+00:00": 165.72999572753906
    },
    "sentiment": 0.9500210285186768
  },
  {
    "title": "BOTOX\u00ae Cosmetic (onabotulinumtoxinA) Reveals 2024 Women Entrepreneur Grant Recipients",
    "published": 1718107200,
    "day_prices": {
      "2024-06-11T13:30:00+00:00": 170.25,
      "2024-06-11T14:30:00+00:00": 168.94500732421875,
      "2024-06-11T15:30:00+00:00": 167.72000122070312,
      "2024-06-11T16:30:00+00:00": 168.1300048828125,
      "2024-06-11T17:30:00+00:00": 167.75999450683594,
      "2024-06-11T18:30:00+00:00": 168.32000732421875,
      "2024-06-11T19:30:00+00:00": 167.89999389648438
    },
    "sentiment": 0.633500874042511
  },
  {
    "title": "Alvotech and Stada add to strategic alliance through denosumab partnership",
    "published": 1718077200,
    "day_prices": {
      "2024-06-11T13:30:00+00:00": 170.25,
      "2024-06-11T14:30:00+00:00": 168.94500732421875,
      "2024-06-11T15:30:00+00:00": 167.72000122070312,
      "2024-06-11T16:30:00+00:00": 168.1300048828125,
      "2024-06-11T17:30:00+00:00": 167.75999450683594,
      "2024-06-11T18:30:00+00:00": 168.32000732421875,
      "2024-06-11T19:30:00+00:00": 167.89999389648438
    },
    "sentiment": 0.8855556845664978
  },
  {
    "title": "Regenxbio: Transforming Gene Therapy With Innovative AAV Treatments, Strong Buy",
    "published": 1718063753,
    "day_prices": {
      "2024-06-10T13:30:00+00:00": 169.0,
      "2024-06-10T14:30:00+00:00": 168.47999572753906,
      "2024-06-10T15:30:00+00:00": 168.14999389648438,
      "2024-06-10T16:30:00+00:00": 168.55999755859375,
      "2024-06-10T17:30:00+00:00": 169.2100067138672,
      "2024-06-10T18:30:00+00:00": 169.6750030517578,
      "2024-06-10T19:30:00+00:00": 170.4600067138672
    },
    "sentiment": 0.9034791588783264
  },
  {
    "title": "Aldeyra: A Speculative Buy Amid Reproxalap's NDA Resubmission",
    "published": 1718025930,
    "day_prices": {
      "2024-06-10T13:30:00+00:00": 169.0,
      "2024-06-10T14:30:00+00:00": 168.47999572753906,
      "2024-06-10T15:30:00+00:00": 168.14999389648438,
      "2024-06-10T16:30:00+00:00": 168.55999755859375,
      "2024-06-10T17:30:00+00:00": 169.2100067138672,
      "2024-06-10T18:30:00+00:00": 169.6750030517578,
      "2024-06-10T19:30:00+00:00": 170.4600067138672
    },
    "sentiment": 0.8405882120132446
  },
  {
    "title": "Pharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval",
    "published": 1717770000,
    "day_prices": {
      "2024-06-07T13:30:00+00:00": 169.0,
      "2024-06-07T14:30:00+00:00": 169.66000366210938,
      "2024-06-07T15:30:00+00:00": 169.92999267578125,
      "2024-06-07T16:30:00+00:00": 169.47999572753906,
      "2024-06-07T17:30:00+00:00": 169.50999450683594,
      "2024-06-07T18:30:00+00:00": 169.80499267578125,
      "2024-06-07T19:30:00+00:00": 169.8300018310547
    },
    "sentiment": 0.5427802801132202
  },
  {
    "title": "Geron wins long-sought drug approval; Califf talks China, GLP-1s at BIO",
    "published": 1717759800,
    "day_prices": {
      "2024-06-07T13:30:00+00:00": 169.0,
      "2024-06-07T14:30:00+00:00": 169.66000366210938,
      "2024-06-07T15:30:00+00:00": 169.92999267578125,
      "2024-06-07T16:30:00+00:00": 169.47999572753906,
      "2024-06-07T17:30:00+00:00": 169.50999450683594,
      "2024-06-07T18:30:00+00:00": 169.80499267578125,
      "2024-06-07T19:30:00+00:00": 169.8300018310547
    },
    "sentiment": 0.7854236364364624
  },
  {
    "title": "AbbVie reports positive Phase II ovarian cancer trial data",
    "published": 1717757200,
    "day_prices": {
      "2024-06-07T13:30:00+00:00": 169.0,
      "2024-06-07T14:30:00+00:00": 169.66000366210938,
      "2024-06-07T15:30:00+00:00": 169.92999267578125,
      "2024-06-07T16:30:00+00:00": 169.47999572753906,
      "2024-06-07T17:30:00+00:00": 169.50999450683594,
      "2024-06-07T18:30:00+00:00": 169.80499267578125,
      "2024-06-07T19:30:00+00:00": 169.8300018310547
    },
    "sentiment": 0.9391255974769592
  },
  {
    "title": "AbbVie-partnered therapy selected for FDA\u2019s rare disease pilot program",
    "published": 1717743840,
    "day_prices": {
      "2024-06-07T13:30:00+00:00": 169.0,
      "2024-06-07T14:30:00+00:00": 169.66000366210938,
      "2024-06-07T15:30:00+00:00": 169.92999267578125,
      "2024-06-07T16:30:00+00:00": 169.47999572753906,
      "2024-06-07T17:30:00+00:00": 169.50999450683594,
      "2024-06-07T18:30:00+00:00": 169.80499267578125,
      "2024-06-07T19:30:00+00:00": 169.8300018310547
    },
    "sentiment": 0.7199091911315918
  },
  {
    "title": "Catalyst Watch: Apple's WWDC, Tesla's annual meeting, Fed's dot plot, and GameStop volatility",
    "published": 1717725720,
    "day_prices": {
      "2024-06-07T13:30:00+00:00": 169.0,
      "2024-06-07T14:30:00+00:00": 169.66000366210938,
      "2024-06-07T15:30:00+00:00": 169.92999267578125,
      "2024-06-07T16:30:00+00:00": 169.47999572753906,
      "2024-06-07T17:30:00+00:00": 169.50999450683594,
      "2024-06-07T18:30:00+00:00": 169.80499267578125,
      "2024-06-07T19:30:00+00:00": 169.8300018310547
    },
    "sentiment": 0.8829655647277832
  },
  {
    "title": "Forget SCHD: Buy Dividend Aristocrats Instead",
    "published": 1717707598,
    "day_prices": {
      "2024-06-06T13:30:00+00:00": 165.49000549316406,
      "2024-06-06T14:30:00+00:00": 167.72999572753906,
      "2024-06-06T15:30:00+00:00": 167.31100463867188,
      "2024-06-06T16:30:00+00:00": 167.3300018310547,
      "2024-06-06T17:30:00+00:00": 167.25999450683594,
      "2024-06-06T18:30:00+00:00": 167.89500427246094,
      "2024-06-06T19:30:00+00:00": 168.50999450683594
    },
    "sentiment": 0.9415252804756165
  },
  {
    "title": "AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug",
    "published": 1717689180,
    "day_prices": {
      "2024-06-06T13:30:00+00:00": 165.49000549316406,
      "2024-06-06T14:30:00+00:00": 167.72999572753906,
      "2024-06-06T15:30:00+00:00": 167.31100463867188,
      "2024-06-06T16:30:00+00:00": 167.3300018310547,
      "2024-06-06T17:30:00+00:00": 167.25999450683594,
      "2024-06-06T18:30:00+00:00": 167.89500427246094,
      "2024-06-06T19:30:00+00:00": 168.50999450683594
    },
    "sentiment": 0.8484346270561218
  },
  {
    "title": "SkinMedica\u00ae Celebrates 25 Years of Empowering Radiant Skin",
    "published": 1717677000,
    "day_prices": {
      "2024-06-06T13:30:00+00:00": 165.49000549316406,
      "2024-06-06T14:30:00+00:00": 167.72999572753906,
      "2024-06-06T15:30:00+00:00": 167.31100463867188,
      "2024-06-06T16:30:00+00:00": 167.3300018310547,
      "2024-06-06T17:30:00+00:00": 167.25999450683594,
      "2024-06-06T18:30:00+00:00": 167.89500427246094,
      "2024-06-06T19:30:00+00:00": 168.50999450683594
    },
    "sentiment": 0.6542264223098755
  },
  {
    "title": "AbbVie Launches First-of-its-Kind Contest to Empower People Living with Migraine in their Careers",
    "published": 1717675200,
    "day_prices": {
      "2024-06-06T13:30:00+00:00": 165.49000549316406,
      "2024-06-06T14:30:00+00:00": 167.72999572753906,
      "2024-06-06T15:30:00+00:00": 167.31100463867188,
      "2024-06-06T16:30:00+00:00": 167.3300018310547,
      "2024-06-06T17:30:00+00:00": 167.25999450683594,
      "2024-06-06T18:30:00+00:00": 167.89500427246094,
      "2024-06-06T19:30:00+00:00": 168.50999450683594
    },
    "sentiment": 0.5133213400840759
  },
  {
    "title": "Interesting ABBV Put And Call Options For July 26th",
    "published": 1717667220,
    "day_prices": {
      "2024-06-06T13:30:00+00:00": 165.49000549316406,
      "2024-06-06T14:30:00+00:00": 167.72999572753906,
      "2024-06-06T15:30:00+00:00": 167.31100463867188,
      "2024-06-06T16:30:00+00:00": 167.3300018310547,
      "2024-06-06T17:30:00+00:00": 167.25999450683594,
      "2024-06-06T18:30:00+00:00": 167.89500427246094,
      "2024-06-06T19:30:00+00:00": 168.50999450683594
    },
    "sentiment": 0.9341078400611877
  },
  {
    "title": "AbbVie treats first subject in Phase III multiple myeloma drug trial",
    "published": 1717663545,
    "day_prices": {
      "2024-06-06T13:30:00+00:00": 165.49000549316406,
      "2024-06-06T14:30:00+00:00": 167.72999572753906,
      "2024-06-06T15:30:00+00:00": 167.31100463867188,
      "2024-06-06T16:30:00+00:00": 167.3300018310547,
      "2024-06-06T17:30:00+00:00": 167.25999450683594,
      "2024-06-06T18:30:00+00:00": 167.89500427246094,
      "2024-06-06T19:30:00+00:00": 168.50999450683594
    },
    "sentiment": 0.7254741191864014
  },
  {
    "title": "AbbVie's mirvetuximab soravtansine meets Phase 2 efficacy endpoint",
    "published": 1717660080,
    "day_prices": {
      "2024-06-06T13:30:00+00:00": 165.49000549316406,
      "2024-06-06T14:30:00+00:00": 167.72999572753906,
      "2024-06-06T15:30:00+00:00": 167.31100463867188,
      "2024-06-06T16:30:00+00:00": 167.3300018310547,
      "2024-06-06T17:30:00+00:00": 167.25999450683594,
      "2024-06-06T18:30:00+00:00": 167.89500427246094,
      "2024-06-06T19:30:00+00:00": 168.50999450683594
    },
    "sentiment": 0.6965237855911255
  },
  {
    "title": "Hold Rating for AbbVie\u2019s Elahere Amidst Market Expansion Potential and Need for Further Data",
    "published": 1717658400,
    "day_prices": {
      "2024-06-06T13:30:00+00:00": 165.49000549316406,
      "2024-06-06T14:30:00+00:00": 167.72999572753906,
      "2024-06-06T15:30:00+00:00": 167.31100463867188,
      "2024-06-06T16:30:00+00:00": 167.3300018310547,
      "2024-06-06T17:30:00+00:00": 167.25999450683594,
      "2024-06-06T18:30:00+00:00": 167.89500427246094,
      "2024-06-06T19:30:00+00:00": 168.50999450683594
    },
    "sentiment": 0.8978680372238159
  },
  {
    "title": "Biotech Blockbusters: 3 Pharma Stocks to Buy in June for Breakthrough Potential",
    "published": 1717623433,
    "day_prices": {
      "2024-06-05T13:30:00+00:00": 162.89999389648438,
      "2024-06-05T14:30:00+00:00": 163.6199951171875,
      "2024-06-05T15:30:00+00:00": 164.77439880371094,
      "2024-06-05T16:30:00+00:00": 164.92999267578125,
      "2024-06-05T17:30:00+00:00": 165.26499938964844,
      "2024-06-05T18:30:00+00:00": 165.77000427246094,
      "2024-06-05T19:30:00+00:00": 165.16000366210938
    },
    "sentiment": 0.5901233553886414
  },
  {
    "title": "Polen Focus Growth Portfolio Q2 2024 Commentary",
    "published": 1722426300,
    "day_prices": {
      "2024-07-31T13:30:00+00:00": 186.38600158691406,
      "2024-07-31T14:30:00+00:00": 186.61000061035156,
      "2024-07-31T15:30:00+00:00": 187.18380737304688,
      "2024-07-31T16:30:00+00:00": 186.35000610351562,
      "2024-07-31T17:30:00+00:00": 186.55499267578125,
      "2024-07-31T18:30:00+00:00": 186.5,
      "2024-07-31T19:30:00+00:00": 184.5749969482422
    },
    "sentiment": 0.9011020064353943
  },
  {
    "title": "A Closer Look at AbbVie's Options Market Dynamics",
    "published": 1722421080,
    "day_prices": {
      "2024-07-31T13:30:00+00:00": 186.38600158691406,
      "2024-07-31T14:30:00+00:00": 186.61000061035156,
      "2024-07-31T15:30:00+00:00": 187.18380737304688,
      "2024-07-31T16:30:00+00:00": 186.35000610351562,
      "2024-07-31T17:30:00+00:00": 186.55499267578125,
      "2024-07-31T18:30:00+00:00": 186.5,
      "2024-07-31T19:30:00+00:00": 184.5749969482422
    },
    "sentiment": 0.9241625666618347
  },
  {
    "title": "Favorite high-yield dividend stocks - BMO",
    "published": 1722417300,
    "day_prices": {
      "2024-07-31T13:30:00+00:00": 186.38600158691406,
      "2024-07-31T14:30:00+00:00": 186.61000061035156,
      "2024-07-31T15:30:00+00:00": 187.18380737304688,
      "2024-07-31T16:30:00+00:00": 186.35000610351562,
      "2024-07-31T17:30:00+00:00": 186.55499267578125,
      "2024-07-31T18:30:00+00:00": 186.5,
      "2024-07-31T19:30:00+00:00": 184.5749969482422
    },
    "sentiment": 0.9192999005317688
  },
  {
    "title": "Cerevel Therapeutics ticks higher amid Nasdaq delisting notice for AbbVie deal",
    "published": 1722412320,
    "day_prices": {
      "2024-07-31T13:30:00+00:00": 186.38600158691406,
      "2024-07-31T14:30:00+00:00": 186.61000061035156,
      "2024-07-31T15:30:00+00:00": 187.18380737304688,
      "2024-07-31T16:30:00+00:00": 186.35000610351562,
      "2024-07-31T17:30:00+00:00": 186.55499267578125,
      "2024-07-31T18:30:00+00:00": 186.5,
      "2024-07-31T19:30:00+00:00": 184.5749969482422
    },
    "sentiment": 0.545481264591217
  },
  {
    "title": "Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know",
    "published": 1722344417,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 183.58999633789062,
      "2024-07-30T14:30:00+00:00": 184.75,
      "2024-07-30T15:30:00+00:00": 185.1999969482422,
      "2024-07-30T16:30:00+00:00": 186.55999755859375,
      "2024-07-30T17:30:00+00:00": 185.92100524902344,
      "2024-07-30T18:30:00+00:00": 186.47000122070312,
      "2024-07-30T19:30:00+00:00": 186.85000610351562
    },
    "sentiment": 0.9365036487579346
  },
  {
    "title": "Allergan Aesthetics Celebrates the Second Annual JUV\u00c9DERM\u00ae Day",
    "published": 1722340800,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 183.58999633789062,
      "2024-07-30T14:30:00+00:00": 184.75,
      "2024-07-30T15:30:00+00:00": 185.1999969482422,
      "2024-07-30T16:30:00+00:00": 186.55999755859375,
      "2024-07-30T17:30:00+00:00": 185.92100524902344,
      "2024-07-30T18:30:00+00:00": 186.47000122070312,
      "2024-07-30T19:30:00+00:00": 186.85000610351562
    },
    "sentiment": 0.8123528361320496
  },
  {
    "title": "Evercore ISI Sticks to Its Buy Rating for AbbVie (ABBV)",
    "published": 1722325500,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 183.58999633789062,
      "2024-07-30T14:30:00+00:00": 184.75,
      "2024-07-30T15:30:00+00:00": 185.1999969482422,
      "2024-07-30T16:30:00+00:00": 186.55999755859375,
      "2024-07-30T17:30:00+00:00": 185.92100524902344,
      "2024-07-30T18:30:00+00:00": 186.47000122070312,
      "2024-07-30T19:30:00+00:00": 186.85000610351562
    },
    "sentiment": 0.7726404070854187
  },
  {
    "title": "Analysts\u2019 Top Healthcare Picks: Edwards Lifesciences (EW), AbbVie (ABBV)",
    "published": 1722318840,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 183.58999633789062,
      "2024-07-30T14:30:00+00:00": 184.75,
      "2024-07-30T15:30:00+00:00": 185.1999969482422,
      "2024-07-30T16:30:00+00:00": 186.55999755859375,
      "2024-07-30T17:30:00+00:00": 185.92100524902344,
      "2024-07-30T18:30:00+00:00": 186.47000122070312,
      "2024-07-30T19:30:00+00:00": 186.85000610351562
    },
    "sentiment": 0.6506852507591248
  },
  {
    "title": "Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Regeneron (REGN), AptarGroup (ATR) and AbbVie (ABBV)",
    "published": 1722302040,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 183.58999633789062,
      "2024-07-30T14:30:00+00:00": 184.75,
      "2024-07-30T15:30:00+00:00": 185.1999969482422,
      "2024-07-30T16:30:00+00:00": 186.55999755859375,
      "2024-07-30T17:30:00+00:00": 185.92100524902344,
      "2024-07-30T18:30:00+00:00": 186.47000122070312,
      "2024-07-30T19:30:00+00:00": 186.85000610351562
    },
    "sentiment": 0.8324586749076843
  },
  {
    "title": "Big Pharma Rallies and Moves Past Obesity",
    "published": 1722249000,
    "day_prices": {
      "2024-07-29T13:30:00+00:00": 184.0399932861328,
      "2024-07-29T14:30:00+00:00": 185.2449951171875,
      "2024-07-29T15:30:00+00:00": 185.3800048828125,
      "2024-07-29T16:30:00+00:00": 182.07000732421875,
      "2024-07-29T17:30:00+00:00": 180.85000610351562,
      "2024-07-29T18:30:00+00:00": 181.94000244140625,
      "2024-07-29T19:30:00+00:00": 182.08999633789062
    },
    "sentiment": 0.7707942128181458
  },
  {
    "title": "AbbVie a Top Socially Responsible Dividend Stock With 3.4% Yield (ABBV)",
    "published": 1722237780,
    "day_prices": {
      "2024-07-29T13:30:00+00:00": 184.0399932861328,
      "2024-07-29T14:30:00+00:00": 185.2449951171875,
      "2024-07-29T15:30:00+00:00": 185.3800048828125,
      "2024-07-29T16:30:00+00:00": 182.07000732421875,
      "2024-07-29T17:30:00+00:00": 180.85000610351562,
      "2024-07-29T18:30:00+00:00": 181.94000244140625,
      "2024-07-29T19:30:00+00:00": 182.08999633789062
    },
    "sentiment": 0.8711715340614319
  },
  {
    "title": "3 Dividend-Paying ETFs to Secure Your Passive Income Stream",
    "published": 1722229320,
    "day_prices": {
      "2024-07-29T13:30:00+00:00": 184.0399932861328,
      "2024-07-29T14:30:00+00:00": 185.2449951171875,
      "2024-07-29T15:30:00+00:00": 185.3800048828125,
      "2024-07-29T16:30:00+00:00": 182.07000732421875,
      "2024-07-29T17:30:00+00:00": 180.85000610351562,
      "2024-07-29T18:30:00+00:00": 181.94000244140625,
      "2024-07-29T19:30:00+00:00": 182.08999633789062
    },
    "sentiment": 0.8814241290092468
  },
  {
    "title": "iShares Biotechnology ETF: Significant Upside Potential As Sector Gains Momentum",
    "published": 1722169530,
    "day_prices": {},
    "sentiment": 0.9490843415260315
  },
  {
    "title": "AbbVie: Q2 Earnings Validate Bullish Case",
    "published": 1722157821,
    "day_prices": {},
    "sentiment": 0.8779703378677368
  },
  {
    "title": "Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzheimer's Association International Conference? 2024 (AAIC?)",
    "published": 1722153900,
    "day_prices": {},
    "sentiment": 0.8622320294380188
  },
  {
    "title": "AbbVie's Immunology Products Continue to Deliver, Morgan Stanley Says",
    "published": 1722009602,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 183.4499969482422,
      "2024-07-26T14:30:00+00:00": 186.32000732421875,
      "2024-07-26T15:30:00+00:00": 185.56500244140625,
      "2024-07-26T16:30:00+00:00": 185.7100067138672,
      "2024-07-26T17:30:00+00:00": 186.64999389648438,
      "2024-07-26T18:30:00+00:00": 186.18499755859375,
      "2024-07-26T19:30:00+00:00": 185.6999969482422
    },
    "sentiment": 0.9479755163192749
  },
  {
    "title": "IN BRIEF: AbbVie receives European approval for Skyrizi",
    "published": 1721998860,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 183.4499969482422,
      "2024-07-26T14:30:00+00:00": 186.32000732421875,
      "2024-07-26T15:30:00+00:00": 185.56500244140625,
      "2024-07-26T16:30:00+00:00": 185.7100067138672,
      "2024-07-26T17:30:00+00:00": 186.64999389648438,
      "2024-07-26T18:30:00+00:00": 186.18499755859375,
      "2024-07-26T19:30:00+00:00": 185.6999969482422
    },
    "sentiment": 0.7277153134346008
  },
  {
    "title": "AbbVie exits Alzheimer\u2019s program on lack of differentiation",
    "published": 1721989200,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 183.4499969482422,
      "2024-07-26T14:30:00+00:00": 186.32000732421875,
      "2024-07-26T15:30:00+00:00": 185.56500244140625,
      "2024-07-26T16:30:00+00:00": 185.7100067138672,
      "2024-07-26T17:30:00+00:00": 186.64999389648438,
      "2024-07-26T18:30:00+00:00": 186.18499755859375,
      "2024-07-26T19:30:00+00:00": 185.6999969482422
    },
    "sentiment": 0.7185729146003723
  },
  {
    "title": "Lockheed Martin To Rally Over 14%? Here Are 10 Top Analyst Forecasts For Friday",
    "published": 1721986080,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 183.4499969482422,
      "2024-07-26T14:30:00+00:00": 186.32000732421875,
      "2024-07-26T15:30:00+00:00": 185.56500244140625,
      "2024-07-26T16:30:00+00:00": 185.7100067138672,
      "2024-07-26T17:30:00+00:00": 186.64999389648438,
      "2024-07-26T18:30:00+00:00": 186.18499755859375,
      "2024-07-26T19:30:00+00:00": 185.6999969482422
    },
    "sentiment": 0.9118914604187012
  },
  {
    "title": "AbbVie Reports Second-Quarter 2024 Financial Results",
    "published": 1721980729,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 183.4499969482422,
      "2024-07-26T14:30:00+00:00": 186.32000732421875,
      "2024-07-26T15:30:00+00:00": 185.56500244140625,
      "2024-07-26T16:30:00+00:00": 185.7100067138672,
      "2024-07-26T17:30:00+00:00": 186.64999389648438,
      "2024-07-26T18:30:00+00:00": 186.18499755859375,
      "2024-07-26T19:30:00+00:00": 185.6999969482422
    },
    "sentiment": 0.8317327499389648
  },
  {
    "title": "Q2 2024 AbbVie Inc Earnings Call",
    "published": 1721978504,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 183.4499969482422,
      "2024-07-26T14:30:00+00:00": 186.32000732421875,
      "2024-07-26T15:30:00+00:00": 185.56500244140625,
      "2024-07-26T16:30:00+00:00": 185.7100067138672,
      "2024-07-26T17:30:00+00:00": 186.64999389648438,
      "2024-07-26T18:30:00+00:00": 186.18499755859375,
      "2024-07-26T19:30:00+00:00": 185.6999969482422
    },
    "sentiment": 0.7790990471839905
  },
  {
    "title": "Truist Financial Sticks to Their Buy Rating for AbbVie (ABBV)",
    "published": 1721975820,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 183.4499969482422,
      "2024-07-26T14:30:00+00:00": 186.32000732421875,
      "2024-07-26T15:30:00+00:00": 185.56500244140625,
      "2024-07-26T16:30:00+00:00": 185.7100067138672,
      "2024-07-26T17:30:00+00:00": 186.64999389648438,
      "2024-07-26T18:30:00+00:00": 186.18499755859375,
      "2024-07-26T19:30:00+00:00": 185.6999969482422
    },
    "sentiment": 0.7924083471298218
  },
  {
    "title": "Buy Rating Affirmed for AbbVie: Strong Commercial Execution and Strategic Growth Post-Humira",
    "published": 1721975220,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 183.4499969482422,
      "2024-07-26T14:30:00+00:00": 186.32000732421875,
      "2024-07-26T15:30:00+00:00": 185.56500244140625,
      "2024-07-26T16:30:00+00:00": 185.7100067138672,
      "2024-07-26T17:30:00+00:00": 186.64999389648438,
      "2024-07-26T18:30:00+00:00": 186.18499755859375,
      "2024-07-26T19:30:00+00:00": 185.6999969482422
    },
    "sentiment": 0.9500490427017212
  },
  {
    "title": "AbbVie announces European Commission approval of Skyrizi",
    "published": 1721967060,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 183.4499969482422,
      "2024-07-26T14:30:00+00:00": 186.32000732421875,
      "2024-07-26T15:30:00+00:00": 185.56500244140625,
      "2024-07-26T16:30:00+00:00": 185.7100067138672,
      "2024-07-26T17:30:00+00:00": 186.64999389648438,
      "2024-07-26T18:30:00+00:00": 186.18499755859375,
      "2024-07-26T19:30:00+00:00": 185.6999969482422
    },
    "sentiment": 0.736214816570282
  },
  {
    "title": "Buy Rating Affirmed for AbbVie Amidst Strong Financials and Strategic Management",
    "published": 1721965680,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 183.4499969482422,
      "2024-07-26T14:30:00+00:00": 186.32000732421875,
      "2024-07-26T15:30:00+00:00": 185.56500244140625,
      "2024-07-26T16:30:00+00:00": 185.7100067138672,
      "2024-07-26T17:30:00+00:00": 186.64999389648438,
      "2024-07-26T18:30:00+00:00": 186.18499755859375,
      "2024-07-26T19:30:00+00:00": 185.6999969482422
    },
    "sentiment": 0.9513617157936096
  },
  {
    "title": "AbbVie Wins Analyst Confidence with Q2 Beat, Diverse Portfolio Fuels Long-Term Growth Expectations",
    "published": 1721959080,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 183.4499969482422,
      "2024-07-26T14:30:00+00:00": 186.32000732421875,
      "2024-07-26T15:30:00+00:00": 185.56500244140625,
      "2024-07-26T16:30:00+00:00": 185.7100067138672,
      "2024-07-26T17:30:00+00:00": 186.64999389648438,
      "2024-07-26T18:30:00+00:00": 186.18499755859375,
      "2024-07-26T19:30:00+00:00": 185.6999969482422
    },
    "sentiment": 0.9521365761756897
  },
  {
    "title": "Why AbbVie Stock Was Cruising Higher on Thursday",
    "published": 1721939102,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 177.0,
      "2024-07-25T14:30:00+00:00": 185.22999572753906,
      "2024-07-25T15:30:00+00:00": 183.0850067138672,
      "2024-07-25T16:30:00+00:00": 183.0800018310547,
      "2024-07-25T17:30:00+00:00": 181.86500549316406,
      "2024-07-25T18:30:00+00:00": 182.2550048828125,
      "2024-07-25T19:30:00+00:00": 182.97000122070312
    },
    "sentiment": 0.7390921711921692
  },
  {
    "title": "AbbVie (ABBV) Q2 2024 Earnings Call Transcript",
    "published": 1721935815,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 177.0,
      "2024-07-25T14:30:00+00:00": 185.22999572753906,
      "2024-07-25T15:30:00+00:00": 183.0850067138672,
      "2024-07-25T16:30:00+00:00": 183.0800018310547,
      "2024-07-25T17:30:00+00:00": 181.86500549316406,
      "2024-07-25T18:30:00+00:00": 182.2550048828125,
      "2024-07-25T19:30:00+00:00": 182.97000122070312
    },
    "sentiment": 0.9247924089431763
  },
  {
    "title": "AbbVie Stock Rises on Strong Sales of Immunology Drugs Other Than Humira",
    "published": 1721925480,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 177.0,
      "2024-07-25T14:30:00+00:00": 185.22999572753906,
      "2024-07-25T15:30:00+00:00": 183.0850067138672,
      "2024-07-25T16:30:00+00:00": 183.0800018310547,
      "2024-07-25T17:30:00+00:00": 181.86500549316406,
      "2024-07-25T18:30:00+00:00": 182.2550048828125,
      "2024-07-25T19:30:00+00:00": 182.97000122070312
    },
    "sentiment": 0.9496663212776184
  },
  {
    "title": "Top Midday Stories: US Advance Q2 GDP Rises; Initial Jobless Claims Drop; Ford Earnings Fall; TotalEnergies' Lower Results; AbbVie Raises Guidance; IBM, ServiceNow Report Higher Results",
    "published": 1721923836,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 177.0,
      "2024-07-25T14:30:00+00:00": 185.22999572753906,
      "2024-07-25T15:30:00+00:00": 183.0850067138672,
      "2024-07-25T16:30:00+00:00": 183.0800018310547,
      "2024-07-25T17:30:00+00:00": 181.86500549316406,
      "2024-07-25T18:30:00+00:00": 182.2550048828125,
      "2024-07-25T19:30:00+00:00": 182.97000122070312
    },
    "sentiment": 0.8819339275360107
  },
  {
    "title": "AbbVie (ABBV) Beats on Q2 Earnings & Sales, Ups '24 EPS View",
    "published": 1721917260,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 177.0,
      "2024-07-25T14:30:00+00:00": 185.22999572753906,
      "2024-07-25T15:30:00+00:00": 183.0850067138672,
      "2024-07-25T16:30:00+00:00": 183.0800018310547,
      "2024-07-25T17:30:00+00:00": 181.86500549316406,
      "2024-07-25T18:30:00+00:00": 182.2550048828125,
      "2024-07-25T19:30:00+00:00": 182.97000122070312
    },
    "sentiment": 0.5820685625076294
  },
  {
    "title": "AbbVie (ABBV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates",
    "published": 1721914232,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 177.0,
      "2024-07-25T14:30:00+00:00": 185.22999572753906,
      "2024-07-25T15:30:00+00:00": 183.0850067138672,
      "2024-07-25T16:30:00+00:00": 183.0800018310547,
      "2024-07-25T17:30:00+00:00": 181.86500549316406,
      "2024-07-25T18:30:00+00:00": 182.2550048828125,
      "2024-07-25T19:30:00+00:00": 182.97000122070312
    },
    "sentiment": 0.9081194400787354
  },
  {
    "title": "AbbVie Inc. (ABBV) Q2 2024 Earnings Call Transcript",
    "published": 1721912647,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 177.0,
      "2024-07-25T14:30:00+00:00": 185.22999572753906,
      "2024-07-25T15:30:00+00:00": 183.0850067138672,
      "2024-07-25T16:30:00+00:00": 183.0800018310547,
      "2024-07-25T17:30:00+00:00": 181.86500549316406,
      "2024-07-25T18:30:00+00:00": 182.2550048828125,
      "2024-07-25T19:30:00+00:00": 182.97000122070312
    },
    "sentiment": 0.9119206666946411
  },
  {
    "title": "Is AbbVie the Best Dividend Stock for You?",
    "published": 1721907900,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 177.0,
      "2024-07-25T14:30:00+00:00": 185.22999572753906,
      "2024-07-25T15:30:00+00:00": 183.0850067138672,
      "2024-07-25T16:30:00+00:00": 183.0800018310547,
      "2024-07-25T17:30:00+00:00": 181.86500549316406,
      "2024-07-25T18:30:00+00:00": 182.2550048828125,
      "2024-07-25T19:30:00+00:00": 182.97000122070312
    },
    "sentiment": 0.8760048747062683
  },
  {
    "title": "AbbVie lifts 2024 profit forecast, shares hit record high",
    "published": 1721907567,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 177.0,
      "2024-07-25T14:30:00+00:00": 185.22999572753906,
      "2024-07-25T15:30:00+00:00": 183.0850067138672,
      "2024-07-25T16:30:00+00:00": 183.0800018310547,
      "2024-07-25T17:30:00+00:00": 181.86500549316406,
      "2024-07-25T18:30:00+00:00": 182.2550048828125,
      "2024-07-25T19:30:00+00:00": 182.97000122070312
    },
    "sentiment": 0.9386755228042603
  },
  {
    "title": "AbbVie Stock News: Why ABBV Is the Top Trending Ticker Today",
    "published": 1721900160,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 177.0,
      "2024-07-25T14:30:00+00:00": 185.22999572753906,
      "2024-07-25T15:30:00+00:00": 183.0850067138672,
      "2024-07-25T16:30:00+00:00": 183.0800018310547,
      "2024-07-25T17:30:00+00:00": 181.86500549316406,
      "2024-07-25T18:30:00+00:00": 182.2550048828125,
      "2024-07-25T19:30:00+00:00": 182.97000122070312
    },
    "sentiment": 0.9128079414367676
  },
  {
    "title": "AbbVie lifts 2024 guidance amid portfolio-wide quarterly sales growth",
    "published": 1721899440,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 177.0,
      "2024-07-25T14:30:00+00:00": 185.22999572753906,
      "2024-07-25T15:30:00+00:00": 183.0850067138672,
      "2024-07-25T16:30:00+00:00": 183.0800018310547,
      "2024-07-25T17:30:00+00:00": 181.86500549316406,
      "2024-07-25T18:30:00+00:00": 182.2550048828125,
      "2024-07-25T19:30:00+00:00": 182.97000122070312
    },
    "sentiment": 0.8944578766822815
  },
  {
    "title": "AbbVie: EPS targets raised for 2024",
    "published": 1721898448,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 177.0,
      "2024-07-25T14:30:00+00:00": 185.22999572753906,
      "2024-07-25T15:30:00+00:00": 183.0850067138672,
      "2024-07-25T16:30:00+00:00": 183.0800018310547,
      "2024-07-25T17:30:00+00:00": 181.86500549316406,
      "2024-07-25T18:30:00+00:00": 182.2550048828125,
      "2024-07-25T19:30:00+00:00": 182.97000122070312
    },
    "sentiment": 0.6962748765945435
  },
  {
    "title": "AbbVie continues to advance Skyrizi's leadership position in psoriasis",
    "published": 1721898300,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 177.0,
      "2024-07-25T14:30:00+00:00": 185.22999572753906,
      "2024-07-25T15:30:00+00:00": 183.0850067138672,
      "2024-07-25T16:30:00+00:00": 183.0800018310547,
      "2024-07-25T17:30:00+00:00": 181.86500549316406,
      "2024-07-25T18:30:00+00:00": 182.2550048828125,
      "2024-07-25T19:30:00+00:00": 182.97000122070312
    },
    "sentiment": 0.8382363319396973
  },
  {
    "title": "AbbVie: Discontinuing development of ABBV-916 as standalone antibody",
    "published": 1721898300,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 177.0,
      "2024-07-25T14:30:00+00:00": 185.22999572753906,
      "2024-07-25T15:30:00+00:00": 183.0850067138672,
      "2024-07-25T16:30:00+00:00": 183.0800018310547,
      "2024-07-25T17:30:00+00:00": 181.86500549316406,
      "2024-07-25T18:30:00+00:00": 182.2550048828125,
      "2024-07-25T19:30:00+00:00": 182.97000122070312
    },
    "sentiment": 0.8206914067268372
  },
  {
    "title": "AbbVie sees FY24 gross margin 84% of sales",
    "published": 1721898300,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 177.0,
      "2024-07-25T14:30:00+00:00": 185.22999572753906,
      "2024-07-25T15:30:00+00:00": 183.0850067138672,
      "2024-07-25T16:30:00+00:00": 183.0800018310547,
      "2024-07-25T17:30:00+00:00": 181.86500549316406,
      "2024-07-25T18:30:00+00:00": 182.2550048828125,
      "2024-07-25T19:30:00+00:00": 182.97000122070312
    },
    "sentiment": 0.8108887672424316
  },
  {
    "title": "AbbVie expects Cerevel Therapeutics transaction to close 'soon'",
    "published": 1721898300,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 177.0,
      "2024-07-25T14:30:00+00:00": 185.22999572753906,
      "2024-07-25T15:30:00+00:00": 183.0850067138672,
      "2024-07-25T16:30:00+00:00": 183.0800018310547,
      "2024-07-25T17:30:00+00:00": 181.86500549316406,
      "2024-07-25T18:30:00+00:00": 182.2550048828125,
      "2024-07-25T19:30:00+00:00": 182.97000122070312
    },
    "sentiment": 0.6036953926086426
  },
  {
    "title": "Cerevel ticks higher as AbbVie says it expects deal to close soon",
    "published": 1721896200,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 177.0,
      "2024-07-25T14:30:00+00:00": 185.22999572753906,
      "2024-07-25T15:30:00+00:00": 183.0850067138672,
      "2024-07-25T16:30:00+00:00": 183.0800018310547,
      "2024-07-25T17:30:00+00:00": 181.86500549316406,
      "2024-07-25T18:30:00+00:00": 182.2550048828125,
      "2024-07-25T19:30:00+00:00": 182.97000122070312
    },
    "sentiment": 0.8435835242271423
  },
  {
    "title": "AbbVie 2Q Revenue Gets Boost From Skyrizi, Rinvoq Sales",
    "published": 1721895560,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 177.0,
      "2024-07-25T14:30:00+00:00": 185.22999572753906,
      "2024-07-25T15:30:00+00:00": 183.0850067138672,
      "2024-07-25T16:30:00+00:00": 183.0800018310547,
      "2024-07-25T17:30:00+00:00": 181.86500549316406,
      "2024-07-25T18:30:00+00:00": 182.2550048828125,
      "2024-07-25T19:30:00+00:00": 182.97000122070312
    },
    "sentiment": 0.9455679655075073
  },
  {
    "title": "AbbVie raises FY24 adjusted EPS view to $10.71-$10.91 from $10.61-$10.81",
    "published": 1721892060,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 177.0,
      "2024-07-25T14:30:00+00:00": 185.22999572753906,
      "2024-07-25T15:30:00+00:00": 183.0850067138672,
      "2024-07-25T16:30:00+00:00": 183.0800018310547,
      "2024-07-25T17:30:00+00:00": 181.86500549316406,
      "2024-07-25T18:30:00+00:00": 182.2550048828125,
      "2024-07-25T19:30:00+00:00": 182.97000122070312
    },
    "sentiment": 0.9356299042701721
  },
  {
    "title": "AbbVie reports Q2 adjusted EPS $2.65, consensus $2.36",
    "published": 1721892060,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 177.0,
      "2024-07-25T14:30:00+00:00": 185.22999572753906,
      "2024-07-25T15:30:00+00:00": 183.0850067138672,
      "2024-07-25T16:30:00+00:00": 183.0800018310547,
      "2024-07-25T17:30:00+00:00": 181.86500549316406,
      "2024-07-25T18:30:00+00:00": 182.2550048828125,
      "2024-07-25T19:30:00+00:00": 182.97000122070312
    },
    "sentiment": 0.501483142375946
  },
  {
    "title": "AbbVie Inc. Q2 Earnings: EPS of $0.77 Misses Estimates, Revenue of $14. ...",
    "published": 1721891520,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 177.0,
      "2024-07-25T14:30:00+00:00": 185.22999572753906,
      "2024-07-25T15:30:00+00:00": 183.0850067138672,
      "2024-07-25T16:30:00+00:00": 183.0800018310547,
      "2024-07-25T17:30:00+00:00": 181.86500549316406,
      "2024-07-25T18:30:00+00:00": 182.2550048828125,
      "2024-07-25T19:30:00+00:00": 182.97000122070312
    },
    "sentiment": 0.8283207416534424
  },
  {
    "title": "Earnings summary: AbbVie reports mixed Q2 results; raises FY24 EPS outlook",
    "published": 1721890140,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 177.0,
      "2024-07-25T14:30:00+00:00": 185.22999572753906,
      "2024-07-25T15:30:00+00:00": 183.0850067138672,
      "2024-07-25T16:30:00+00:00": 183.0800018310547,
      "2024-07-25T17:30:00+00:00": 181.86500549316406,
      "2024-07-25T18:30:00+00:00": 182.2550048828125,
      "2024-07-25T19:30:00+00:00": 182.97000122070312
    },
    "sentiment": 0.9396465420722961
  },
  {
    "title": "The Zacks Analyst Blog Highlights Boston Scientific, Thermo Fisher Scientific, Align Technology and Edwards Lifesciences",
    "published": 1721827140,
    "day_prices": {
      "2024-07-24T13:30:00+00:00": 173.1999969482422,
      "2024-07-24T14:30:00+00:00": 173.6074981689453,
      "2024-07-24T15:30:00+00:00": 174.3468017578125,
      "2024-07-24T16:30:00+00:00": 175.74000549316406,
      "2024-07-24T17:30:00+00:00": 175.92649841308594,
      "2024-07-24T18:30:00+00:00": 176.0500030517578,
      "2024-07-24T19:30:00+00:00": 176.49000549316406
    },
    "sentiment": 0.9425097107887268
  },
  {
    "title": "AbbVie Q2 Earnings Preview: Focus on the new era of the company",
    "published": 1721819520,
    "day_prices": {
      "2024-07-24T13:30:00+00:00": 173.1999969482422,
      "2024-07-24T14:30:00+00:00": 173.6074981689453,
      "2024-07-24T15:30:00+00:00": 174.3468017578125,
      "2024-07-24T16:30:00+00:00": 175.74000549316406,
      "2024-07-24T17:30:00+00:00": 175.92649841308594,
      "2024-07-24T18:30:00+00:00": 176.0500030517578,
      "2024-07-24T19:30:00+00:00": 176.49000549316406
    },
    "sentiment": 0.8908677101135254
  },
  {
    "title": "My Dividend Stock Portfolio: New June Dividend Record - 101 Holdings With 22 Buys",
    "published": 1721808600,
    "day_prices": {
      "2024-07-24T13:30:00+00:00": 173.1999969482422,
      "2024-07-24T14:30:00+00:00": 173.6074981689453,
      "2024-07-24T15:30:00+00:00": 174.3468017578125,
      "2024-07-24T16:30:00+00:00": 175.74000549316406,
      "2024-07-24T17:30:00+00:00": 175.92649841308594,
      "2024-07-24T18:30:00+00:00": 176.0500030517578,
      "2024-07-24T19:30:00+00:00": 176.49000549316406
    },
    "sentiment": 0.8427462577819824
  },
  {
    "title": "Cellectar: WM Treatment Data Leads To A Few Regulatory Milestones",
    "published": 1721747341,
    "day_prices": {
      "2024-07-23T13:30:00+00:00": 173.32000732421875,
      "2024-07-23T14:30:00+00:00": 174.27999877929688,
      "2024-07-23T15:30:00+00:00": 173.24000549316406,
      "2024-07-23T16:30:00+00:00": 173.28500366210938,
      "2024-07-23T17:30:00+00:00": 173.1999969482422,
      "2024-07-23T18:30:00+00:00": 173.3000030517578,
      "2024-07-23T19:30:00+00:00": 173.1199951171875
    },
    "sentiment": 0.8303079009056091
  },
  {
    "title": "These 4 Measures Indicate That AbbVie (NYSE:ABBV) Is Using Debt Reasonably Well",
    "published": 1721739612,
    "day_prices": {
      "2024-07-23T13:30:00+00:00": 173.32000732421875,
      "2024-07-23T14:30:00+00:00": 174.27999877929688,
      "2024-07-23T15:30:00+00:00": 173.24000549316406,
      "2024-07-23T16:30:00+00:00": 173.28500366210938,
      "2024-07-23T17:30:00+00:00": 173.1999969482422,
      "2024-07-23T18:30:00+00:00": 173.3000030517578,
      "2024-07-23T19:30:00+00:00": 173.1199951171875
    },
    "sentiment": 0.7224782109260559
  },
  {
    "title": "Frontier Medicines announces milestone payment in AbbVie partnership",
    "published": 1721714580,
    "day_prices": {
      "2024-07-23T13:30:00+00:00": 173.32000732421875,
      "2024-07-23T14:30:00+00:00": 174.27999877929688,
      "2024-07-23T15:30:00+00:00": 173.24000549316406,
      "2024-07-23T16:30:00+00:00": 173.28500366210938,
      "2024-07-23T17:30:00+00:00": 173.1999969482422,
      "2024-07-23T18:30:00+00:00": 173.3000030517578,
      "2024-07-23T19:30:00+00:00": 173.1199951171875
    },
    "sentiment": 0.6337065696716309
  },
  {
    "title": "Piper Sandler Sticks to Its Buy Rating for AbbVie (ABBV)",
    "published": 1721713200,
    "day_prices": {
      "2024-07-23T13:30:00+00:00": 173.32000732421875,
      "2024-07-23T14:30:00+00:00": 174.27999877929688,
      "2024-07-23T15:30:00+00:00": 173.24000549316406,
      "2024-07-23T16:30:00+00:00": 173.28500366210938,
      "2024-07-23T17:30:00+00:00": 173.1999969482422,
      "2024-07-23T18:30:00+00:00": 173.3000030517578,
      "2024-07-23T19:30:00+00:00": 173.1199951171875
    },
    "sentiment": 0.8173243999481201
  },
  {
    "title": "AbbVie Could Soar 24%, According to a Wall Street Analyst. Is the High-Yield Dividend Stock a Buy Now?",
    "published": 1721659260,
    "day_prices": {
      "2024-07-22T13:30:00+00:00": 173.32000732421875,
      "2024-07-22T14:30:00+00:00": 172.48500061035156,
      "2024-07-22T15:30:00+00:00": 173.47000122070312,
      "2024-07-22T16:30:00+00:00": 173.69000244140625,
      "2024-07-22T17:30:00+00:00": 174.110107421875,
      "2024-07-22T18:30:00+00:00": 173.2899932861328,
      "2024-07-22T19:30:00+00:00": 173.25999450683594
    },
    "sentiment": 0.8640621900558472
  },
  {
    "title": "AbbVie (ABBV) Stock Before Q2 Earnings: To Buy or Not to Buy?",
    "published": 1721656140,
    "day_prices": {
      "2024-07-22T13:30:00+00:00": 173.32000732421875,
      "2024-07-22T14:30:00+00:00": 172.48500061035156,
      "2024-07-22T15:30:00+00:00": 173.47000122070312,
      "2024-07-22T16:30:00+00:00": 173.69000244140625,
      "2024-07-22T17:30:00+00:00": 174.110107421875,
      "2024-07-22T18:30:00+00:00": 173.2899932861328,
      "2024-07-22T19:30:00+00:00": 173.25999450683594
    },
    "sentiment": 0.9064977765083313
  },
  {
    "title": "AbbVie (ABBV) Fell as its Arthritis Drug Went Off Patent",
    "published": 1721644479,
    "day_prices": {
      "2024-07-22T13:30:00+00:00": 173.32000732421875,
      "2024-07-22T14:30:00+00:00": 172.48500061035156,
      "2024-07-22T15:30:00+00:00": 173.47000122070312,
      "2024-07-22T16:30:00+00:00": 173.69000244140625,
      "2024-07-22T17:30:00+00:00": 174.110107421875,
      "2024-07-22T18:30:00+00:00": 173.2899932861328,
      "2024-07-22T19:30:00+00:00": 173.25999450683594
    },
    "sentiment": 0.9722850322723389
  },
  {
    "title": "Cerevel Therapeutics gains as investors appear more confident on FTC approval for AbbVie",
    "published": 1721617800,
    "day_prices": {
      "2024-07-22T13:30:00+00:00": 173.32000732421875,
      "2024-07-22T14:30:00+00:00": 172.48500061035156,
      "2024-07-22T15:30:00+00:00": 173.47000122070312,
      "2024-07-22T16:30:00+00:00": 173.69000244140625,
      "2024-07-22T17:30:00+00:00": 174.110107421875,
      "2024-07-22T18:30:00+00:00": 173.2899932861328,
      "2024-07-22T19:30:00+00:00": 173.25999450683594
    },
    "sentiment": 0.9504120945930481
  },
  {
    "title": "Kamala Harris' potential impact on health care stocks",
    "published": 1721549220,
    "day_prices": {},
    "sentiment": 0.49974942207336426
  },
  {
    "title": "Financials dominate in Q2 as Wall Street slides amidst concerns on tech - Earnings Scorecard",
    "published": 1721444340,
    "day_prices": {},
    "sentiment": 0.9675024151802063
  },
  {
    "title": "Tesla, Alphabet, Visa earnings, June PCE data: What to watch",
    "published": 1721424828,
    "day_prices": {
      "2024-07-19T13:30:00+00:00": 173.6699981689453,
      "2024-07-19T14:30:00+00:00": 171.68499755859375,
      "2024-07-19T15:30:00+00:00": 171.5,
      "2024-07-19T16:30:00+00:00": 171.97500610351562,
      "2024-07-19T17:30:00+00:00": 171.52000427246094,
      "2024-07-19T18:30:00+00:00": 171.44500732421875,
      "2024-07-19T19:30:00+00:00": 171.7899932861328
    },
    "sentiment": 0.9357274174690247
  },
  {
    "title": "Stocks to watch next week: Tesla, Microsoft, Alphabet and Amazon",
    "published": 1721400228,
    "day_prices": {
      "2024-07-19T13:30:00+00:00": 173.6699981689453,
      "2024-07-19T14:30:00+00:00": 171.68499755859375,
      "2024-07-19T15:30:00+00:00": 171.5,
      "2024-07-19T16:30:00+00:00": 171.97500610351562,
      "2024-07-19T17:30:00+00:00": 171.52000427246094,
      "2024-07-19T18:30:00+00:00": 171.44500732421875,
      "2024-07-19T19:30:00+00:00": 171.7899932861328
    },
    "sentiment": 0.9406037330627441
  },
  {
    "title": "Pharma Stock Roundup: JNJ, NVS Q2 Earnings, RHHBY's Positive Obesity Pill Data",
    "published": 1721395560,
    "day_prices": {
      "2024-07-19T13:30:00+00:00": 173.6699981689453,
      "2024-07-19T14:30:00+00:00": 171.68499755859375,
      "2024-07-19T15:30:00+00:00": 171.5,
      "2024-07-19T16:30:00+00:00": 171.97500610351562,
      "2024-07-19T17:30:00+00:00": 171.52000427246094,
      "2024-07-19T18:30:00+00:00": 171.44500732421875,
      "2024-07-19T19:30:00+00:00": 171.7899932861328
    },
    "sentiment": 0.6262761354446411
  },
  {
    "title": "Why Novartis Deserves Your Attention After Q2 2024 Results",
    "published": 1721384154,
    "day_prices": {
      "2024-07-19T13:30:00+00:00": 173.6699981689453,
      "2024-07-19T14:30:00+00:00": 171.68499755859375,
      "2024-07-19T15:30:00+00:00": 171.5,
      "2024-07-19T16:30:00+00:00": 171.97500610351562,
      "2024-07-19T17:30:00+00:00": 171.52000427246094,
      "2024-07-19T18:30:00+00:00": 171.44500732421875,
      "2024-07-19T19:30:00+00:00": 171.7899932861328
    },
    "sentiment": 0.8967504501342773
  },
  {
    "title": "Catalyst watch: Earnings deluge, Farnborough Airshow, Paris Olympics, and Trump talks crypto",
    "published": 1721354460,
    "day_prices": {
      "2024-07-19T13:30:00+00:00": 173.6699981689453,
      "2024-07-19T14:30:00+00:00": 171.68499755859375,
      "2024-07-19T15:30:00+00:00": 171.5,
      "2024-07-19T16:30:00+00:00": 171.97500610351562,
      "2024-07-19T17:30:00+00:00": 171.52000427246094,
      "2024-07-19T18:30:00+00:00": 171.44500732421875,
      "2024-07-19T19:30:00+00:00": 171.7899932861328
    },
    "sentiment": 0.8376867771148682
  },
  {
    "title": "Earnings Preview: AbbVie (ABBV) Q2 Earnings Expected to Decline",
    "published": 1721311283,
    "day_prices": {
      "2024-07-18T13:30:00+00:00": 174.44500732421875,
      "2024-07-18T14:30:00+00:00": 176.27999877929688,
      "2024-07-18T15:30:00+00:00": 176.00999450683594,
      "2024-07-18T16:30:00+00:00": 175.83999633789062,
      "2024-07-18T17:30:00+00:00": 174.8350067138672,
      "2024-07-18T18:30:00+00:00": 172.46499633789062,
      "2024-07-18T19:30:00+00:00": 171.4600067138672
    },
    "sentiment": 0.9575141072273254
  },
  {
    "title": "GoodRx partners with Boehringer Ingelheim to discount Humira biosimilar",
    "published": 1721296812,
    "day_prices": {
      "2024-07-18T13:30:00+00:00": 174.44500732421875,
      "2024-07-18T14:30:00+00:00": 176.27999877929688,
      "2024-07-18T15:30:00+00:00": 176.00999450683594,
      "2024-07-18T16:30:00+00:00": 175.83999633789062,
      "2024-07-18T17:30:00+00:00": 174.8350067138672,
      "2024-07-18T18:30:00+00:00": 172.46499633789062,
      "2024-07-18T19:30:00+00:00": 171.4600067138672
    },
    "sentiment": 0.7339712381362915
  },
  {
    "title": "7 High-Yield Dividend Stocks to Help Pay Your Bills",
    "published": 1721240310,
    "day_prices": {
      "2024-07-17T13:30:00+00:00": 169.50999450683594,
      "2024-07-17T14:30:00+00:00": 174.52999877929688,
      "2024-07-17T15:30:00+00:00": 173.75999450683594,
      "2024-07-17T16:30:00+00:00": 174.36000061035156,
      "2024-07-17T17:30:00+00:00": 174.6999969482422,
      "2024-07-17T18:30:00+00:00": 174.4600067138672,
      "2024-07-17T19:30:00+00:00": 175.1300048828125
    },
    "sentiment": 0.9018194079399109
  },
  {
    "title": "AbbVie\u2019s Humira loss of exclusivity has been a missed opportunity for competitors",
    "published": 1721228010,
    "day_prices": {
      "2024-07-17T13:30:00+00:00": 169.50999450683594,
      "2024-07-17T14:30:00+00:00": 174.52999877929688,
      "2024-07-17T15:30:00+00:00": 173.75999450683594,
      "2024-07-17T16:30:00+00:00": 174.36000061035156,
      "2024-07-17T17:30:00+00:00": 174.6999969482422,
      "2024-07-17T18:30:00+00:00": 174.4600067138672,
      "2024-07-17T19:30:00+00:00": 175.1300048828125
    },
    "sentiment": 0.9505112767219543
  },
  {
    "title": "3 Absurdly Cheap Stocks to Buy and Hold for Years",
    "published": 1721219100,
    "day_prices": {
      "2024-07-17T13:30:00+00:00": 169.50999450683594,
      "2024-07-17T14:30:00+00:00": 174.52999877929688,
      "2024-07-17T15:30:00+00:00": 173.75999450683594,
      "2024-07-17T16:30:00+00:00": 174.36000061035156,
      "2024-07-17T17:30:00+00:00": 174.6999969482422,
      "2024-07-17T18:30:00+00:00": 174.4600067138672,
      "2024-07-17T19:30:00+00:00": 175.1300048828125
    },
    "sentiment": 0.889814019203186
  },
  {
    "title": "Analysts Have Conflicting Sentiments on These Healthcare Companies: AbbVie (ABBV), GoodRx Holdings (GDRX) and Organon (OGN)",
    "published": 1721215260,
    "day_prices": {
      "2024-07-17T13:30:00+00:00": 169.50999450683594,
      "2024-07-17T14:30:00+00:00": 174.52999877929688,
      "2024-07-17T15:30:00+00:00": 173.75999450683594,
      "2024-07-17T16:30:00+00:00": 174.36000061035156,
      "2024-07-17T17:30:00+00:00": 174.6999969482422,
      "2024-07-17T18:30:00+00:00": 174.4600067138672,
      "2024-07-17T19:30:00+00:00": 175.1300048828125
    },
    "sentiment": 0.9474892020225525
  },
  {
    "title": "ASCO Annual Meeting 2024: Breakthrough Treatments Hint At Renewed Hope For Patients And Investors",
    "published": 1721191320,
    "day_prices": {
      "2024-07-17T13:30:00+00:00": 169.50999450683594,
      "2024-07-17T14:30:00+00:00": 174.52999877929688,
      "2024-07-17T15:30:00+00:00": 173.75999450683594,
      "2024-07-17T16:30:00+00:00": 174.36000061035156,
      "2024-07-17T17:30:00+00:00": 174.6999969482422,
      "2024-07-17T18:30:00+00:00": 174.4600067138672,
      "2024-07-17T19:30:00+00:00": 175.1300048828125
    },
    "sentiment": 0.9093031287193298
  },
  {
    "title": "7 High-Yield Dividend Stocks Beating Inflation",
    "published": 1721152800,
    "day_prices": {
      "2024-07-16T13:30:00+00:00": 168.60000610351562,
      "2024-07-16T14:30:00+00:00": 168.8800048828125,
      "2024-07-16T15:30:00+00:00": 168.3800048828125,
      "2024-07-16T16:30:00+00:00": 168.87950134277344,
      "2024-07-16T17:30:00+00:00": 168.36000061035156,
      "2024-07-16T18:30:00+00:00": 169.38999938964844,
      "2024-07-16T19:30:00+00:00": 168.92999267578125
    },
    "sentiment": 0.7957503795623779
  },
  {
    "title": "7 Recession-Proof Stocks to Shield Your Portfolio in 2024",
    "published": 1721124000,
    "day_prices": {
      "2024-07-16T13:30:00+00:00": 168.60000610351562,
      "2024-07-16T14:30:00+00:00": 168.8800048828125,
      "2024-07-16T15:30:00+00:00": 168.3800048828125,
      "2024-07-16T16:30:00+00:00": 168.87950134277344,
      "2024-07-16T17:30:00+00:00": 168.36000061035156,
      "2024-07-16T18:30:00+00:00": 169.38999938964844,
      "2024-07-16T19:30:00+00:00": 168.92999267578125
    },
    "sentiment": 0.8382173180580139
  },
  {
    "title": "AbbVie looks to add an eighth indication for JAK inhibitor Rinvoq",
    "published": 1721058827,
    "day_prices": {
      "2024-07-15T13:30:00+00:00": 168.77999877929688,
      "2024-07-15T14:30:00+00:00": 169.53500366210938,
      "2024-07-15T15:30:00+00:00": 168.24000549316406,
      "2024-07-15T16:30:00+00:00": 168.39999389648438,
      "2024-07-15T17:30:00+00:00": 168.00999450683594,
      "2024-07-15T18:30:00+00:00": 168.10000610351562,
      "2024-07-15T19:30:00+00:00": 168.02999877929688
    },
    "sentiment": 0.6158848404884338
  },
  {
    "title": "Should You Be Excited About AbbVie Inc.'s (NYSE:ABBV) 75% Return On Equity?",
    "published": 1721048412,
    "day_prices": {
      "2024-07-15T13:30:00+00:00": 168.77999877929688,
      "2024-07-15T14:30:00+00:00": 169.53500366210938,
      "2024-07-15T15:30:00+00:00": 168.24000549316406,
      "2024-07-15T16:30:00+00:00": 168.39999389648438,
      "2024-07-15T17:30:00+00:00": 168.00999450683594,
      "2024-07-15T18:30:00+00:00": 168.10000610351562,
      "2024-07-15T19:30:00+00:00": 168.02999877929688
    },
    "sentiment": 0.7177067995071411
  },
  {
    "title": "AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib in Giant Cell Arteritis",
    "published": 1721021420,
    "day_prices": {
      "2024-07-15T13:30:00+00:00": 168.77999877929688,
      "2024-07-15T14:30:00+00:00": 169.53500366210938,
      "2024-07-15T15:30:00+00:00": 168.24000549316406,
      "2024-07-15T16:30:00+00:00": 168.39999389648438,
      "2024-07-15T17:30:00+00:00": 168.00999450683594,
      "2024-07-15T18:30:00+00:00": 168.10000610351562,
      "2024-07-15T19:30:00+00:00": 168.02999877929688
    },
    "sentiment": 0.6773781776428223
  },
  {
    "title": "Wall Street Brunch: Trump 'Fine' After Shooting",
    "published": 1720947900,
    "day_prices": {},
    "sentiment": 0.603242814540863
  },
  {
    "title": "AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ\u00ae) in Giant Cell Arteritis",
    "published": 1720787400,
    "day_prices": {
      "2024-07-12T13:30:00+00:00": 170.6300048828125,
      "2024-07-12T14:30:00+00:00": 170.90499877929688,
      "2024-07-12T15:30:00+00:00": 170.82000732421875,
      "2024-07-12T16:30:00+00:00": 170.13999938964844,
      "2024-07-12T17:30:00+00:00": 170.4199981689453,
      "2024-07-12T18:30:00+00:00": 171.11000061035156,
      "2024-07-12T19:30:00+00:00": 171.22999572753906
    },
    "sentiment": 0.6574745178222656
  },
  {
    "title": "AbbVie (ABBV) Gains As Market Dips: What You Should Know",
    "published": 1720734317,
    "day_prices": {
      "2024-07-11T13:30:00+00:00": 167.52000427246094,
      "2024-07-11T14:30:00+00:00": 169.47439575195312,
      "2024-07-11T15:30:00+00:00": 169.4199981689453,
      "2024-07-11T16:30:00+00:00": 169.51499938964844,
      "2024-07-11T17:30:00+00:00": 169.3350067138672,
      "2024-07-11T18:30:00+00:00": 169.88999938964844,
      "2024-07-11T19:30:00+00:00": 169.4600067138672
    },
    "sentiment": 0.7997487187385559
  },
  {
    "title": "AbbVie Announces Appointment of Roopal Thakkar, M.D. as Executive Vice President, Research and Development and Chief Scientific Officer",
    "published": 1720692448,
    "day_prices": {
      "2024-07-11T13:30:00+00:00": 167.52000427246094,
      "2024-07-11T14:30:00+00:00": 169.47439575195312,
      "2024-07-11T15:30:00+00:00": 169.4199981689453,
      "2024-07-11T16:30:00+00:00": 169.51499938964844,
      "2024-07-11T17:30:00+00:00": 169.3350067138672,
      "2024-07-11T18:30:00+00:00": 169.88999938964844,
      "2024-07-11T19:30:00+00:00": 169.4600067138672
    },
    "sentiment": 0.9157742261886597
  },
  {
    "title": "Top Stock Reports for Novo Nordisk, AbbVie & AstraZeneca",
    "published": 1720642080,
    "day_prices": {
      "2024-07-10T13:30:00+00:00": 167.4499969482422,
      "2024-07-10T14:30:00+00:00": 167.6300048828125,
      "2024-07-10T15:30:00+00:00": 167.72999572753906,
      "2024-07-10T16:30:00+00:00": 167.22000122070312,
      "2024-07-10T17:30:00+00:00": 167.0,
      "2024-07-10T18:30:00+00:00": 166.67999267578125,
      "2024-07-10T19:30:00+00:00": 167.13499450683594
    },
    "sentiment": 0.9486340880393982
  },
  {
    "title": "AbbVie names new R&D head; Arcutis eczema cream approved",
    "published": 1720612080,
    "day_prices": {
      "2024-07-10T13:30:00+00:00": 167.4499969482422,
      "2024-07-10T14:30:00+00:00": 167.6300048828125,
      "2024-07-10T15:30:00+00:00": 167.72999572753906,
      "2024-07-10T16:30:00+00:00": 167.22000122070312,
      "2024-07-10T17:30:00+00:00": 167.0,
      "2024-07-10T18:30:00+00:00": 166.67999267578125,
      "2024-07-10T19:30:00+00:00": 167.13499450683594
    },
    "sentiment": 0.8531891107559204
  },
  {
    "title": "Neurocrine's Pipeline, Including Crinecerfont's Priority Review, Drives Long-Term Growth",
    "published": 1720521135,
    "day_prices": {
      "2024-07-09T13:30:00+00:00": 167.02000427246094,
      "2024-07-09T14:30:00+00:00": 166.2899932861328,
      "2024-07-09T15:30:00+00:00": 167.44500732421875,
      "2024-07-09T16:30:00+00:00": 167.6123046875,
      "2024-07-09T17:30:00+00:00": 168.16000366210938,
      "2024-07-09T18:30:00+00:00": 167.85000610351562,
      "2024-07-09T19:30:00+00:00": 167.77000427246094
    },
    "sentiment": 0.7708568572998047
  },
  {
    "title": "The Smartest Dividend Stocks to Buy With $250 Right Now",
    "published": 1720432200,
    "day_prices": {
      "2024-07-08T13:30:00+00:00": 166.5399932861328,
      "2024-07-08T14:30:00+00:00": 167.6699981689453,
      "2024-07-08T15:30:00+00:00": 166.58999633789062,
      "2024-07-08T16:30:00+00:00": 166.33900451660156,
      "2024-07-08T17:30:00+00:00": 166.55999755859375,
      "2024-07-08T18:30:00+00:00": 166.58529663085938,
      "2024-07-08T19:30:00+00:00": 166.71499633789062
    },
    "sentiment": 0.8788288831710815
  },
  {
    "title": "Dividend Champion, Contender, And Challenger Highlights: Week Of July 7",
    "published": 1720261632,
    "day_prices": {},
    "sentiment": 0.9110743999481201
  },
  {
    "title": "Global Anti-Obesity Market Analysis: Key Trends And Insights",
    "published": 1720092600,
    "day_prices": {},
    "sentiment": 0.9219270944595337
  },
  {
    "title": "AbbVie Q2 Preview: Upgrade To Buy - Better Late Than Never",
    "published": 1720087101,
    "day_prices": {},
    "sentiment": 0.882282018661499
  },
  {
    "title": "AbbVie : Results of Operations and Financial Condition Form 8 K",
    "published": 1720015866,
    "day_prices": {
      "2024-07-03T13:30:00+00:00": 166.08999633789062,
      "2024-07-03T14:30:00+00:00": 165.7445068359375,
      "2024-07-03T15:30:00+00:00": 164.36000061035156
    },
    "sentiment": 0.9375891089439392
  },
  {
    "title": "AbbVie: A Hold Again (Rating Downgrade)",
    "published": 1719981520,
    "day_prices": {
      "2024-07-03T13:30:00+00:00": 166.08999633789062,
      "2024-07-03T14:30:00+00:00": 165.7445068359375,
      "2024-07-03T15:30:00+00:00": 164.36000061035156
    },
    "sentiment": 0.8581557273864746
  },
  {
    "title": "SCHD: A No-Brainer ETF With A Growing 4% Yield",
    "published": 1719922587,
    "day_prices": {
      "2024-07-02T13:30:00+00:00": 168.6300048828125,
      "2024-07-02T14:30:00+00:00": 167.1649932861328,
      "2024-07-02T15:30:00+00:00": 167.52999877929688,
      "2024-07-02T16:30:00+00:00": 166.77999877929688,
      "2024-07-02T17:30:00+00:00": 165.49000549316406,
      "2024-07-02T18:30:00+00:00": 166.74000549316406,
      "2024-07-02T19:30:00+00:00": 166.3800048828125
    },
    "sentiment": 0.8702132701873779
  },
  {
    "title": "AbbVie to Host Second-Quarter 2024 Earnings Conference Call",
    "published": 1719921600,
    "day_prices": {
      "2024-07-02T13:30:00+00:00": 168.6300048828125,
      "2024-07-02T14:30:00+00:00": 167.1649932861328,
      "2024-07-02T15:30:00+00:00": 167.52999877929688,
      "2024-07-02T16:30:00+00:00": 166.77999877929688,
      "2024-07-02T17:30:00+00:00": 165.49000549316406,
      "2024-07-02T18:30:00+00:00": 166.74000549316406,
      "2024-07-02T19:30:00+00:00": 166.3800048828125
    },
    "sentiment": 0.919191837310791
  },
  {
    "title": "3 Under-the-Radar Biotech Stocks With Blockbuster Potential",
    "published": 1719915840,
    "day_prices": {
      "2024-07-02T13:30:00+00:00": 168.6300048828125,
      "2024-07-02T14:30:00+00:00": 167.1649932861328,
      "2024-07-02T15:30:00+00:00": 167.52999877929688,
      "2024-07-02T16:30:00+00:00": 166.77999877929688,
      "2024-07-02T17:30:00+00:00": 165.49000549316406,
      "2024-07-02T18:30:00+00:00": 166.74000549316406,
      "2024-07-02T19:30:00+00:00": 166.3800048828125
    },
    "sentiment": 0.6027727723121643
  },
  {
    "title": "2 High-Yielding Healthcare Stocks to Buy With $1,000 in July",
    "published": 1719845280,
    "day_prices": {
      "2024-07-01T13:30:00+00:00": 171.27000427246094,
      "2024-07-01T14:30:00+00:00": 171.47999572753906,
      "2024-07-01T15:30:00+00:00": 171.0800018310547,
      "2024-07-01T16:30:00+00:00": 170.9550018310547,
      "2024-07-01T17:30:00+00:00": 171.07000732421875,
      "2024-07-01T18:30:00+00:00": 169.875,
      "2024-07-01T19:30:00+00:00": 169.9499969482422
    },
    "sentiment": 0.7719076871871948
  },
  {
    "title": "Robert A. Michael Assumes Role as AbbVie Chief Executive Officer",
    "published": 1719835200,
    "day_prices": {
      "2024-07-01T13:30:00+00:00": 171.27000427246094,
      "2024-07-01T14:30:00+00:00": 171.47999572753906,
      "2024-07-01T15:30:00+00:00": 171.0800018310547,
      "2024-07-01T16:30:00+00:00": 170.9550018310547,
      "2024-07-01T17:30:00+00:00": 171.07000732421875,
      "2024-07-01T18:30:00+00:00": 169.875,
      "2024-07-01T19:30:00+00:00": 169.9499969482422
    },
    "sentiment": 0.9218472242355347
  },
  {
    "title": "AbbVie: new CEO takes up post",
    "published": 1719830357,
    "day_prices": {
      "2024-07-01T13:30:00+00:00": 171.27000427246094,
      "2024-07-01T14:30:00+00:00": 171.47999572753906,
      "2024-07-01T15:30:00+00:00": 171.0800018310547,
      "2024-07-01T16:30:00+00:00": 170.9550018310547,
      "2024-07-01T17:30:00+00:00": 171.07000732421875,
      "2024-07-01T18:30:00+00:00": 169.875,
      "2024-07-01T19:30:00+00:00": 169.9499969482422
    },
    "sentiment": 0.8782661557197571
  },
  {
    "title": "Aldeyra Therapeutics Inc (NASDAQ:ALDX) A Bull Case Theory",
    "published": 1725028704,
    "day_prices": {
      "2024-08-30T13:30:00+00:00": 195.25,
      "2024-08-30T14:30:00+00:00": 195.92999267578125,
      "2024-08-30T15:30:00+00:00": 194.53500366210938,
      "2024-08-30T16:30:00+00:00": 194.2949981689453,
      "2024-08-30T17:30:00+00:00": 194.78900146484375,
      "2024-08-30T18:30:00+00:00": 194.9199981689453,
      "2024-08-30T19:30:00+00:00": 195.13999938964844
    },
    "sentiment": 0.9336057305335999
  },
  {
    "title": "Columbia Dividend Income Fund Q2 2024 Investment Commentary",
    "published": 1725024000,
    "day_prices": {
      "2024-08-30T13:30:00+00:00": 195.25,
      "2024-08-30T14:30:00+00:00": 195.92999267578125,
      "2024-08-30T15:30:00+00:00": 194.53500366210938,
      "2024-08-30T16:30:00+00:00": 194.2949981689453,
      "2024-08-30T17:30:00+00:00": 194.78900146484375,
      "2024-08-30T18:30:00+00:00": 194.9199981689453,
      "2024-08-30T19:30:00+00:00": 195.13999938964844
    },
    "sentiment": 0.9342978000640869
  },
  {
    "title": "SCHD's Achilles Heel: A Warning To Dividend Investors",
    "published": 1725015945,
    "day_prices": {
      "2024-08-30T13:30:00+00:00": 195.25,
      "2024-08-30T14:30:00+00:00": 195.92999267578125,
      "2024-08-30T15:30:00+00:00": 194.53500366210938,
      "2024-08-30T16:30:00+00:00": 194.2949981689453,
      "2024-08-30T17:30:00+00:00": 194.78900146484375,
      "2024-08-30T18:30:00+00:00": 194.9199981689453,
      "2024-08-30T19:30:00+00:00": 195.13999938964844
    },
    "sentiment": 0.7941864132881165
  },
  {
    "title": "2 Incredibly Cheap Healthcare Stocks to Buy Now",
    "published": 1725006000,
    "day_prices": {
      "2024-08-30T13:30:00+00:00": 195.25,
      "2024-08-30T14:30:00+00:00": 195.92999267578125,
      "2024-08-30T15:30:00+00:00": 194.53500366210938,
      "2024-08-30T16:30:00+00:00": 194.2949981689453,
      "2024-08-30T17:30:00+00:00": 194.78900146484375,
      "2024-08-30T18:30:00+00:00": 194.9199981689453,
      "2024-08-30T19:30:00+00:00": 195.13999938964844
    },
    "sentiment": 0.8107355833053589
  },
  {
    "title": "Neurocrine Stock Down 19% on Mixed Schizophrenia Study Results",
    "published": 1724945520,
    "day_prices": {
      "2024-08-29T13:30:00+00:00": 196.0,
      "2024-08-29T14:30:00+00:00": 196.0399932861328,
      "2024-08-29T15:30:00+00:00": 195.97000122070312,
      "2024-08-29T16:30:00+00:00": 196.02499389648438,
      "2024-08-29T17:30:00+00:00": 195.6999969482422,
      "2024-08-29T18:30:00+00:00": 195.5399932861328,
      "2024-08-29T19:30:00+00:00": 195.6699981689453
    },
    "sentiment": 0.9733936190605164
  },
  {
    "title": "AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know",
    "published": 1724936418,
    "day_prices": {
      "2024-08-29T13:30:00+00:00": 196.0,
      "2024-08-29T14:30:00+00:00": 196.0399932861328,
      "2024-08-29T15:30:00+00:00": 195.97000122070312,
      "2024-08-29T16:30:00+00:00": 196.02499389648438,
      "2024-08-29T17:30:00+00:00": 195.6999969482422,
      "2024-08-29T18:30:00+00:00": 195.5399932861328,
      "2024-08-29T19:30:00+00:00": 195.6699981689453
    },
    "sentiment": 0.9242390394210815
  },
  {
    "title": "Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?",
    "published": 1724926807,
    "day_prices": {
      "2024-08-29T13:30:00+00:00": 196.0,
      "2024-08-29T14:30:00+00:00": 196.0399932861328,
      "2024-08-29T15:30:00+00:00": 195.97000122070312,
      "2024-08-29T16:30:00+00:00": 196.02499389648438,
      "2024-08-29T17:30:00+00:00": 195.6999969482422,
      "2024-08-29T18:30:00+00:00": 195.5399932861328,
      "2024-08-29T19:30:00+00:00": 195.6699981689453
    },
    "sentiment": 0.6477481722831726
  },
  {
    "title": "Bull Market Buys: 3 Dividend Stocks to Own for the Long Run",
    "published": 1724925000,
    "day_prices": {
      "2024-08-29T13:30:00+00:00": 196.0,
      "2024-08-29T14:30:00+00:00": 196.0399932861328,
      "2024-08-29T15:30:00+00:00": 195.97000122070312,
      "2024-08-29T16:30:00+00:00": 196.02499389648438,
      "2024-08-29T17:30:00+00:00": 195.6999969482422,
      "2024-08-29T18:30:00+00:00": 195.5399932861328,
      "2024-08-29T19:30:00+00:00": 195.6699981689453
    },
    "sentiment": 0.9139292240142822
  },
  {
    "title": "New Medicare drug price caps could help seniors save over $1,000 a year - AARP",
    "published": 1724909280,
    "day_prices": {
      "2024-08-29T13:30:00+00:00": 196.0,
      "2024-08-29T14:30:00+00:00": 196.0399932861328,
      "2024-08-29T15:30:00+00:00": 195.97000122070312,
      "2024-08-29T16:30:00+00:00": 196.02499389648438,
      "2024-08-29T17:30:00+00:00": 195.6999969482422,
      "2024-08-29T18:30:00+00:00": 195.5399932861328,
      "2024-08-29T19:30:00+00:00": 195.6699981689453
    },
    "sentiment": 0.8434953689575195
  },
  {
    "title": "As Regulators Gear Up To Decide On Bristol Myers' Schizophrenia Treatment, Neurocrine Biosciences' Data Disappoints Investors",
    "published": 1724858186,
    "day_prices": {
      "2024-08-28T13:30:00+00:00": 195.52000427246094,
      "2024-08-28T14:30:00+00:00": 194.13999938964844,
      "2024-08-28T15:30:00+00:00": 195.17999267578125,
      "2024-08-28T16:30:00+00:00": 194.47999572753906,
      "2024-08-28T17:30:00+00:00": 194.57000732421875,
      "2024-08-28T18:30:00+00:00": 194.86000061035156,
      "2024-08-28T19:30:00+00:00": 195.14999389648438
    },
    "sentiment": 0.8175347447395325
  },
  {
    "title": "Amgen: Growth Is Still A Better Choice",
    "published": 1724845735,
    "day_prices": {
      "2024-08-28T13:30:00+00:00": 195.52000427246094,
      "2024-08-28T14:30:00+00:00": 194.13999938964844,
      "2024-08-28T15:30:00+00:00": 195.17999267578125,
      "2024-08-28T16:30:00+00:00": 194.47999572753906,
      "2024-08-28T17:30:00+00:00": 194.57000732421875,
      "2024-08-28T18:30:00+00:00": 194.86000061035156,
      "2024-08-28T19:30:00+00:00": 195.14999389648438
    },
    "sentiment": 0.7617878317832947
  },
  {
    "title": "Prediction: Eli Lilly's Latest Move Will Threaten AbbVie Stock",
    "published": 1724841120,
    "day_prices": {
      "2024-08-28T13:30:00+00:00": 195.52000427246094,
      "2024-08-28T14:30:00+00:00": 194.13999938964844,
      "2024-08-28T15:30:00+00:00": 195.17999267578125,
      "2024-08-28T16:30:00+00:00": 194.47999572753906,
      "2024-08-28T17:30:00+00:00": 194.57000732421875,
      "2024-08-28T18:30:00+00:00": 194.86000061035156,
      "2024-08-28T19:30:00+00:00": 195.14999389648438
    },
    "sentiment": 0.9402761459350586
  },
  {
    "title": "AbbVie Broke Out Again, So Wait For A Pullback Before Buying More",
    "published": 1724834821,
    "day_prices": {
      "2024-08-28T13:30:00+00:00": 195.52000427246094,
      "2024-08-28T14:30:00+00:00": 194.13999938964844,
      "2024-08-28T15:30:00+00:00": 195.17999267578125,
      "2024-08-28T16:30:00+00:00": 194.47999572753906,
      "2024-08-28T17:30:00+00:00": 194.57000732421875,
      "2024-08-28T18:30:00+00:00": 194.86000061035156,
      "2024-08-28T19:30:00+00:00": 195.14999389648438
    },
    "sentiment": 0.8470761775970459
  },
  {
    "title": "AbbVie: I'm Up 149% And Holding This Dividend Aristocrat Now",
    "published": 1724830200,
    "day_prices": {
      "2024-08-28T13:30:00+00:00": 195.52000427246094,
      "2024-08-28T14:30:00+00:00": 194.13999938964844,
      "2024-08-28T15:30:00+00:00": 195.17999267578125,
      "2024-08-28T16:30:00+00:00": 194.47999572753906,
      "2024-08-28T17:30:00+00:00": 194.57000732421875,
      "2024-08-28T18:30:00+00:00": 194.86000061035156,
      "2024-08-28T19:30:00+00:00": 195.14999389648438
    },
    "sentiment": 0.6069283485412598
  },
  {
    "title": "Why AbbVie Remains One Of My Favorite Dividend Growers",
    "published": 1724776838,
    "day_prices": {
      "2024-08-27T13:30:00+00:00": 197.99000549316406,
      "2024-08-27T14:30:00+00:00": 196.17999267578125,
      "2024-08-27T15:30:00+00:00": 195.86000061035156,
      "2024-08-27T16:30:00+00:00": 195.6999969482422,
      "2024-08-27T17:30:00+00:00": 195.6999969482422,
      "2024-08-27T18:30:00+00:00": 195.63999938964844,
      "2024-08-27T19:30:00+00:00": 195.5937957763672
    },
    "sentiment": 0.8540363311767578
  },
  {
    "title": "SkinMedica\u00ae Revolutionizes Skin Hydration with the Introduction of HA5\u00ae Hydra Collagen Replenish + Restore Hydrator",
    "published": 1724760300,
    "day_prices": {
      "2024-08-27T13:30:00+00:00": 197.99000549316406,
      "2024-08-27T14:30:00+00:00": 196.17999267578125,
      "2024-08-27T15:30:00+00:00": 195.86000061035156,
      "2024-08-27T16:30:00+00:00": 195.6999969482422,
      "2024-08-27T17:30:00+00:00": 195.6999969482422,
      "2024-08-27T18:30:00+00:00": 195.63999938964844,
      "2024-08-27T19:30:00+00:00": 195.5937957763672
    },
    "sentiment": 0.5330508351325989
  },
  {
    "title": "PGIM Jennison Health Sciences Fund Q2 2024 Commentary",
    "published": 1724759100,
    "day_prices": {
      "2024-08-27T13:30:00+00:00": 197.99000549316406,
      "2024-08-27T14:30:00+00:00": 196.17999267578125,
      "2024-08-27T15:30:00+00:00": 195.86000061035156,
      "2024-08-27T16:30:00+00:00": 195.6999969482422,
      "2024-08-27T17:30:00+00:00": 195.6999969482422,
      "2024-08-27T18:30:00+00:00": 195.63999938964844,
      "2024-08-27T19:30:00+00:00": 195.5937957763672
    },
    "sentiment": 0.947090744972229
  },
  {
    "title": "SkinMedica? Revolutionizes Skin Hydration with the Introduction of HA5? Hydra Collagen Replenish + Restore Hydrator",
    "published": 1724745900,
    "day_prices": {
      "2024-08-27T13:30:00+00:00": 197.99000549316406,
      "2024-08-27T14:30:00+00:00": 196.17999267578125,
      "2024-08-27T15:30:00+00:00": 195.86000061035156,
      "2024-08-27T16:30:00+00:00": 195.6999969482422,
      "2024-08-27T17:30:00+00:00": 195.6999969482422,
      "2024-08-27T18:30:00+00:00": 195.63999938964844,
      "2024-08-27T19:30:00+00:00": 195.5937957763672
    },
    "sentiment": 0.6369678974151611
  },
  {
    "title": "GSK's Q2 Success Amid Challenges: What Investors Need To Know",
    "published": 1724673194,
    "day_prices": {
      "2024-08-26T13:30:00+00:00": 197.55999755859375,
      "2024-08-26T14:30:00+00:00": 197.27000427246094,
      "2024-08-26T15:30:00+00:00": 197.49000549316406,
      "2024-08-26T16:30:00+00:00": 197.16000366210938,
      "2024-08-26T17:30:00+00:00": 197.55999755859375,
      "2024-08-26T18:30:00+00:00": 197.27999877929688,
      "2024-08-26T19:30:00+00:00": 196.9499969482422
    },
    "sentiment": 0.9054468274116516
  },
  {
    "title": "AbbVie Unusual Options Activity For August 26",
    "published": 1724635200,
    "day_prices": {
      "2024-08-26T13:30:00+00:00": 197.55999755859375,
      "2024-08-26T14:30:00+00:00": 197.27000427246094,
      "2024-08-26T15:30:00+00:00": 197.49000549316406,
      "2024-08-26T16:30:00+00:00": 197.16000366210938,
      "2024-08-26T17:30:00+00:00": 197.55999755859375,
      "2024-08-26T18:30:00+00:00": 197.27999877929688,
      "2024-08-26T19:30:00+00:00": 196.9499969482422
    },
    "sentiment": 0.640886127948761
  },
  {
    "title": "Should You Be Excited About AbbVie Inc.'s (NYSE:ABBV) 78% Return On Equity?",
    "published": 1724590816,
    "day_prices": {},
    "sentiment": 0.7895264029502869
  },
  {
    "title": "Analysis-Ozempic on Wall Street's list for 2027 Medicare drug negotiations",
    "published": 1724414686,
    "day_prices": {
      "2024-08-23T13:30:00+00:00": 197.25,
      "2024-08-23T14:30:00+00:00": 197.52999877929688,
      "2024-08-23T15:30:00+00:00": 197.27999877929688,
      "2024-08-23T16:30:00+00:00": 196.6800994873047,
      "2024-08-23T17:30:00+00:00": 196.64999389648438,
      "2024-08-23T18:30:00+00:00": 197.20599365234375,
      "2024-08-23T19:30:00+00:00": 197.67999267578125
    },
    "sentiment": 0.8122782707214355
  },
  {
    "title": "AbbVie price target raised by $13 at Piper Sandler, here's why",
    "published": 1724402400,
    "day_prices": {
      "2024-08-23T13:30:00+00:00": 197.25,
      "2024-08-23T14:30:00+00:00": 197.52999877929688,
      "2024-08-23T15:30:00+00:00": 197.27999877929688,
      "2024-08-23T16:30:00+00:00": 196.6800994873047,
      "2024-08-23T17:30:00+00:00": 196.64999389648438,
      "2024-08-23T18:30:00+00:00": 197.20599365234375,
      "2024-08-23T19:30:00+00:00": 197.67999267578125
    },
    "sentiment": 0.7721096277236938
  },
  {
    "title": "How To Build A Dividend Growth Portfolio In An Overpriced Market",
    "published": 1724316420,
    "day_prices": {
      "2024-08-22T13:30:00+00:00": 197.0050048828125,
      "2024-08-22T14:30:00+00:00": 196.41000366210938,
      "2024-08-22T15:30:00+00:00": 195.6699981689453,
      "2024-08-22T16:30:00+00:00": 196.0850067138672,
      "2024-08-22T17:30:00+00:00": 195.68820190429688,
      "2024-08-22T18:30:00+00:00": 196.00999450683594,
      "2024-08-22T19:30:00+00:00": 196.3000030517578
    },
    "sentiment": 0.8471556305885315
  },
  {
    "title": "AbbVie (ABBV) Gets Nod in EU for Lymphoma Drug's Expanded Use",
    "published": 1724161440,
    "day_prices": {
      "2024-08-20T13:30:00+00:00": 197.1199951171875,
      "2024-08-20T14:30:00+00:00": 195.2100067138672,
      "2024-08-20T15:30:00+00:00": 195.4499969482422,
      "2024-08-20T16:30:00+00:00": 195.61000061035156,
      "2024-08-20T17:30:00+00:00": 196.30499267578125,
      "2024-08-20T18:30:00+00:00": 196.74000549316406,
      "2024-08-20T19:30:00+00:00": 195.90499877929688
    },
    "sentiment": 0.9418886303901672
  },
  {
    "title": "EC approves AbbVie\u2019s TEPKINLY for follicular lymphoma",
    "published": 1724142803,
    "day_prices": {
      "2024-08-20T13:30:00+00:00": 197.1199951171875,
      "2024-08-20T14:30:00+00:00": 195.2100067138672,
      "2024-08-20T15:30:00+00:00": 195.4499969482422,
      "2024-08-20T16:30:00+00:00": 195.61000061035156,
      "2024-08-20T17:30:00+00:00": 196.30499267578125,
      "2024-08-20T18:30:00+00:00": 196.74000549316406,
      "2024-08-20T19:30:00+00:00": 195.90499877929688
    },
    "sentiment": 0.6333144903182983
  },
  {
    "title": "FTC says FDA biosimilar guidance would increase competition, lead to lower prices",
    "published": 1724116140,
    "day_prices": {
      "2024-08-20T13:30:00+00:00": 197.1199951171875,
      "2024-08-20T14:30:00+00:00": 195.2100067138672,
      "2024-08-20T15:30:00+00:00": 195.4499969482422,
      "2024-08-20T16:30:00+00:00": 195.61000061035156,
      "2024-08-20T17:30:00+00:00": 196.30499267578125,
      "2024-08-20T18:30:00+00:00": 196.74000549316406,
      "2024-08-20T19:30:00+00:00": 195.90499877929688
    },
    "sentiment": 0.5784028768539429
  },
  {
    "title": "European Commission Grants Second Indication Approval for TEPKINLY\u00ae (epcoritamab) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma",
    "published": 1724090700,
    "day_prices": {
      "2024-08-19T13:30:00+00:00": 193.39999389648438,
      "2024-08-19T14:30:00+00:00": 196.11000061035156,
      "2024-08-19T15:30:00+00:00": 196.5399932861328,
      "2024-08-19T16:30:00+00:00": 196.4199981689453,
      "2024-08-19T17:30:00+00:00": 196.24000549316406,
      "2024-08-19T18:30:00+00:00": 196.17999267578125,
      "2024-08-19T19:30:00+00:00": 196.7100067138672
    },
    "sentiment": 0.9349774122238159
  },
  {
    "title": "European Commission Grants Second Indication Approval for TEPKINLY? (epcoritamab) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma",
    "published": 1724076300,
    "day_prices": {
      "2024-08-19T13:30:00+00:00": 193.39999389648438,
      "2024-08-19T14:30:00+00:00": 196.11000061035156,
      "2024-08-19T15:30:00+00:00": 196.5399932861328,
      "2024-08-19T16:30:00+00:00": 196.4199981689453,
      "2024-08-19T17:30:00+00:00": 196.24000549316406,
      "2024-08-19T18:30:00+00:00": 196.17999267578125,
      "2024-08-19T19:30:00+00:00": 196.7100067138672
    },
    "sentiment": 0.9352107048034668
  },
  {
    "title": "DUHP: A Quality ETF With Market Performance, Lower Volatility",
    "published": 1724053131,
    "day_prices": {
      "2024-08-19T13:30:00+00:00": 193.39999389648438,
      "2024-08-19T14:30:00+00:00": 196.11000061035156,
      "2024-08-19T15:30:00+00:00": 196.5399932861328,
      "2024-08-19T16:30:00+00:00": 196.4199981689453,
      "2024-08-19T17:30:00+00:00": 196.24000549316406,
      "2024-08-19T18:30:00+00:00": 196.17999267578125,
      "2024-08-19T19:30:00+00:00": 196.7100067138672
    },
    "sentiment": 0.701229989528656
  },
  {
    "title": "Small-cap and mid-cap Health Care has room to rally - Roth MKM",
    "published": 1724033580,
    "day_prices": {
      "2024-08-19T13:30:00+00:00": 193.39999389648438,
      "2024-08-19T14:30:00+00:00": 196.11000061035156,
      "2024-08-19T15:30:00+00:00": 196.5399932861328,
      "2024-08-19T16:30:00+00:00": 196.4199981689453,
      "2024-08-19T17:30:00+00:00": 196.24000549316406,
      "2024-08-19T18:30:00+00:00": 196.17999267578125,
      "2024-08-19T19:30:00+00:00": 196.7100067138672
    },
    "sentiment": 0.7902528047561646
  },
  {
    "title": "AbbVie announces European Commission approval for Tepkinly for second indication",
    "published": 1724029800,
    "day_prices": {
      "2024-08-19T13:30:00+00:00": 193.39999389648438,
      "2024-08-19T14:30:00+00:00": 196.11000061035156,
      "2024-08-19T15:30:00+00:00": 196.5399932861328,
      "2024-08-19T16:30:00+00:00": 196.4199981689453,
      "2024-08-19T17:30:00+00:00": 196.24000549316406,
      "2024-08-19T18:30:00+00:00": 196.17999267578125,
      "2024-08-19T19:30:00+00:00": 196.7100067138672
    },
    "sentiment": 0.7818536162376404
  },
  {
    "title": "3 High-Yield Stocks to Buy Now That Have Increased Their Dividends for 25 Years or More",
    "published": 1723974600,
    "day_prices": {},
    "sentiment": 0.8744155764579773
  },
  {
    "title": "3 High-Yielding Dividend Growth Stocks That Retirees Can Rely On for Recurring Income",
    "published": 1723903200,
    "day_prices": {},
    "sentiment": 0.7661336660385132
  },
  {
    "title": "AVK: Trying To Take Advantage Of Market Developments, But Hard To Justify A Premium",
    "published": 1723869123,
    "day_prices": {},
    "sentiment": 0.8141965270042419
  },
  {
    "title": "IXJ: Healthcare Sector\u00a0Dashboard For August",
    "published": 1723743322,
    "day_prices": {
      "2024-08-15T13:30:00+00:00": 194.72999572753906,
      "2024-08-15T14:30:00+00:00": 191.72000122070312,
      "2024-08-15T15:30:00+00:00": 192.11000061035156,
      "2024-08-15T16:30:00+00:00": 192.47500610351562,
      "2024-08-15T17:30:00+00:00": 191.8699951171875,
      "2024-08-15T18:30:00+00:00": 192.1199951171875,
      "2024-08-15T19:30:00+00:00": 193.22999572753906
    },
    "sentiment": 0.9193373918533325
  },
  {
    "title": "AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It",
    "published": 1723726818,
    "day_prices": {
      "2024-08-15T13:30:00+00:00": 194.72999572753906,
      "2024-08-15T14:30:00+00:00": 191.72000122070312,
      "2024-08-15T15:30:00+00:00": 192.11000061035156,
      "2024-08-15T16:30:00+00:00": 192.47500610351562,
      "2024-08-15T17:30:00+00:00": 191.8699951171875,
      "2024-08-15T18:30:00+00:00": 192.1199951171875,
      "2024-08-15T19:30:00+00:00": 193.22999572753906
    },
    "sentiment": 0.9343089461326599
  },
  {
    "title": "Medicare to save $6B in 2026 from the first ever Part D drug pricing negotiations",
    "published": 1723722548,
    "day_prices": {
      "2024-08-15T13:30:00+00:00": 194.72999572753906,
      "2024-08-15T14:30:00+00:00": 191.72000122070312,
      "2024-08-15T15:30:00+00:00": 192.11000061035156,
      "2024-08-15T16:30:00+00:00": 192.47500610351562,
      "2024-08-15T17:30:00+00:00": 191.8699951171875,
      "2024-08-15T18:30:00+00:00": 192.1199951171875,
      "2024-08-15T19:30:00+00:00": 193.22999572753906
    },
    "sentiment": 0.7243971824645996
  },
  {
    "title": "Morning Brew: Alibaba's Mixed Results and Walmart's Strong Performance Highlight Market Activity",
    "published": 1723707960,
    "day_prices": {
      "2024-08-15T13:30:00+00:00": 194.72999572753906,
      "2024-08-15T14:30:00+00:00": 191.72000122070312,
      "2024-08-15T15:30:00+00:00": 192.11000061035156,
      "2024-08-15T16:30:00+00:00": 192.47500610351562,
      "2024-08-15T17:30:00+00:00": 191.8699951171875,
      "2024-08-15T18:30:00+00:00": 192.1199951171875,
      "2024-08-15T19:30:00+00:00": 193.22999572753906
    },
    "sentiment": 0.7423295974731445
  },
  {
    "title": "U.S. announces final drug prices after Medicare negotiations",
    "published": 1723704360,
    "day_prices": {
      "2024-08-15T13:30:00+00:00": 194.72999572753906,
      "2024-08-15T14:30:00+00:00": 191.72000122070312,
      "2024-08-15T15:30:00+00:00": 192.11000061035156,
      "2024-08-15T16:30:00+00:00": 192.47500610351562,
      "2024-08-15T17:30:00+00:00": 191.8699951171875,
      "2024-08-15T18:30:00+00:00": 192.1199951171875,
      "2024-08-15T19:30:00+00:00": 193.22999572753906
    },
    "sentiment": 0.8023656606674194
  },
  {
    "title": "U.S. government targets $6B in saving from first Medicare drug price negotiations",
    "published": 1723703280,
    "day_prices": {
      "2024-08-15T13:30:00+00:00": 194.72999572753906,
      "2024-08-15T14:30:00+00:00": 191.72000122070312,
      "2024-08-15T15:30:00+00:00": 192.11000061035156,
      "2024-08-15T16:30:00+00:00": 192.47500610351562,
      "2024-08-15T17:30:00+00:00": 191.8699951171875,
      "2024-08-15T18:30:00+00:00": 192.1199951171875,
      "2024-08-15T19:30:00+00:00": 193.22999572753906
    },
    "sentiment": 0.7020659446716309
  },
  {
    "title": "The 3 Best Stocks to Buy to Survive Another S&P 500 Crash",
    "published": 1723697345,
    "day_prices": {
      "2024-08-15T13:30:00+00:00": 194.72999572753906,
      "2024-08-15T14:30:00+00:00": 191.72000122070312,
      "2024-08-15T15:30:00+00:00": 192.11000061035156,
      "2024-08-15T16:30:00+00:00": 192.47500610351562,
      "2024-08-15T17:30:00+00:00": 191.8699951171875,
      "2024-08-15T18:30:00+00:00": 192.1199951171875,
      "2024-08-15T19:30:00+00:00": 193.22999572753906
    },
    "sentiment": 0.785975992679596
  },
  {
    "title": "Teva's Transformation: From Generics Leader To Branded Drug Innovator",
    "published": 1723647937,
    "day_prices": {
      "2024-08-14T13:30:00+00:00": 191.0,
      "2024-08-14T14:30:00+00:00": 192.27000427246094,
      "2024-08-14T15:30:00+00:00": 192.8699951171875,
      "2024-08-14T16:30:00+00:00": 192.77999877929688,
      "2024-08-14T17:30:00+00:00": 192.49000549316406,
      "2024-08-14T18:30:00+00:00": 192.5399932861328,
      "2024-08-14T19:30:00+00:00": 192.75
    },
    "sentiment": 0.5589566826820374
  },
  {
    "title": "The Zacks Analyst Blog Highlights Alphabet, AbbVie, Qualcomm and Flanigan's",
    "published": 1723640460,
    "day_prices": {
      "2024-08-14T13:30:00+00:00": 191.0,
      "2024-08-14T14:30:00+00:00": 192.27000427246094,
      "2024-08-14T15:30:00+00:00": 192.8699951171875,
      "2024-08-14T16:30:00+00:00": 192.77999877929688,
      "2024-08-14T17:30:00+00:00": 192.49000549316406,
      "2024-08-14T18:30:00+00:00": 192.5399932861328,
      "2024-08-14T19:30:00+00:00": 192.75
    },
    "sentiment": 0.9412729144096375
  },
  {
    "title": "Decoding AbbVie's Options Activity: What's the Big Picture?",
    "published": 1723637280,
    "day_prices": {
      "2024-08-14T13:30:00+00:00": 191.0,
      "2024-08-14T14:30:00+00:00": 192.27000427246094,
      "2024-08-14T15:30:00+00:00": 192.8699951171875,
      "2024-08-14T16:30:00+00:00": 192.77999877929688,
      "2024-08-14T17:30:00+00:00": 192.49000549316406,
      "2024-08-14T18:30:00+00:00": 192.5399932861328,
      "2024-08-14T19:30:00+00:00": 192.75
    },
    "sentiment": 0.9205624461174011
  },
  {
    "title": "3 Big Drug Stocks to Watch on Raised 2024 Earnings & Sales View",
    "published": 1723559220,
    "day_prices": {
      "2024-08-13T13:30:00+00:00": 190.55999755859375,
      "2024-08-13T14:30:00+00:00": 189.7949981689453,
      "2024-08-13T15:30:00+00:00": 189.66000366210938,
      "2024-08-13T16:30:00+00:00": 189.7418975830078,
      "2024-08-13T17:30:00+00:00": 190.0,
      "2024-08-13T18:30:00+00:00": 190.22500610351562,
      "2024-08-13T19:30:00+00:00": 191.02999877929688
    },
    "sentiment": 0.9244531393051147
  },
  {
    "title": "Corbus Pharmaceuticals: A Pause In The Rally Likely",
    "published": 1723483425,
    "day_prices": {
      "2024-08-12T13:30:00+00:00": 190.0800018310547,
      "2024-08-12T14:30:00+00:00": 189.22799682617188,
      "2024-08-12T15:30:00+00:00": 189.6999969482422,
      "2024-08-12T16:30:00+00:00": 190.22000122070312,
      "2024-08-12T17:30:00+00:00": 189.7144012451172,
      "2024-08-12T18:30:00+00:00": 189.3300018310547,
      "2024-08-12T19:30:00+00:00": 189.4199981689453
    },
    "sentiment": 0.8893781900405884
  },
  {
    "title": "Big Drugmakers Are Clinching Smaller Deals",
    "published": 1723455000,
    "day_prices": {
      "2024-08-12T13:30:00+00:00": 190.0800018310547,
      "2024-08-12T14:30:00+00:00": 189.22799682617188,
      "2024-08-12T15:30:00+00:00": 189.6999969482422,
      "2024-08-12T16:30:00+00:00": 190.22000122070312,
      "2024-08-12T17:30:00+00:00": 189.7144012451172,
      "2024-08-12T18:30:00+00:00": 189.3300018310547,
      "2024-08-12T19:30:00+00:00": 189.4199981689453
    },
    "sentiment": 0.8207560777664185
  },
  {
    "title": "AbbVie price target lowered by $7 at Morgan Stanley, here's why",
    "published": 1723449180,
    "day_prices": {
      "2024-08-12T13:30:00+00:00": 190.0800018310547,
      "2024-08-12T14:30:00+00:00": 189.22799682617188,
      "2024-08-12T15:30:00+00:00": 189.6999969482422,
      "2024-08-12T16:30:00+00:00": 190.22000122070312,
      "2024-08-12T17:30:00+00:00": 189.7144012451172,
      "2024-08-12T18:30:00+00:00": 189.3300018310547,
      "2024-08-12T19:30:00+00:00": 189.4199981689453
    },
    "sentiment": 0.759328305721283
  },
  {
    "title": "Texas probes CenterPoint, Carlyle weighs Nobian sale: Monday Buzz",
    "published": 1723432740,
    "day_prices": {
      "2024-08-12T13:30:00+00:00": 190.0800018310547,
      "2024-08-12T14:30:00+00:00": 189.22799682617188,
      "2024-08-12T15:30:00+00:00": 189.6999969482422,
      "2024-08-12T16:30:00+00:00": 190.22000122070312,
      "2024-08-12T17:30:00+00:00": 189.7144012451172,
      "2024-08-12T18:30:00+00:00": 189.3300018310547,
      "2024-08-12T19:30:00+00:00": 189.4199981689453
    },
    "sentiment": 0.9161480665206909
  },
  {
    "title": "3 Stocks Retirees Should Absolutely Love",
    "published": 1723287000,
    "day_prices": {},
    "sentiment": 0.8872469663619995
  },
  {
    "title": "Dividend Champion, Contender, And Challenger Highlights: Week Of August 11",
    "published": 1723271988,
    "day_prices": {},
    "sentiment": 0.9048931002616882
  },
  {
    "title": "Building A $100,000 Dividend Portfolio With 3 ETFs And 3 Stocks",
    "published": 1723205745,
    "day_prices": {
      "2024-08-09T13:30:00+00:00": 190.77999877929688,
      "2024-08-09T14:30:00+00:00": 188.8000030517578,
      "2024-08-09T15:30:00+00:00": 188.69000244140625,
      "2024-08-09T16:30:00+00:00": 189.10000610351562,
      "2024-08-09T17:30:00+00:00": 189.85000610351562,
      "2024-08-09T18:30:00+00:00": 189.29530334472656,
      "2024-08-09T19:30:00+00:00": 189.5
    },
    "sentiment": 0.8791942000389099
  },
  {
    "title": "2 High Yielding Recession Proof Dividend Picks For A Massive Income Snowball",
    "published": 1723168946,
    "day_prices": {
      "2024-08-09T13:30:00+00:00": 190.77999877929688,
      "2024-08-09T14:30:00+00:00": 188.8000030517578,
      "2024-08-09T15:30:00+00:00": 188.69000244140625,
      "2024-08-09T16:30:00+00:00": 189.10000610351562,
      "2024-08-09T17:30:00+00:00": 189.85000610351562,
      "2024-08-09T18:30:00+00:00": 189.29530334472656,
      "2024-08-09T19:30:00+00:00": 189.5
    },
    "sentiment": 0.6117433309555054
  },
  {
    "title": "Aldeyra climbs after late-stage success for dry eye disease therapy",
    "published": 1723116720,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 186.9199981689453,
      "2024-08-08T14:30:00+00:00": 189.33999633789062,
      "2024-08-08T15:30:00+00:00": 189.25999450683594,
      "2024-08-08T16:30:00+00:00": 189.72500610351562,
      "2024-08-08T17:30:00+00:00": 189.86000061035156,
      "2024-08-08T18:30:00+00:00": 190.36500549316406,
      "2024-08-08T19:30:00+00:00": 189.67999267578125
    },
    "sentiment": 0.8822838068008423
  },
  {
    "title": "13 Stocks Make Investors $200 Billion Richer As The Rest Collapse",
    "published": 1723032005,
    "day_prices": {
      "2024-08-07T13:30:00+00:00": 187.89999389648438,
      "2024-08-07T14:30:00+00:00": 188.25999450683594,
      "2024-08-07T15:30:00+00:00": 188.0800018310547,
      "2024-08-07T16:30:00+00:00": 187.6300048828125,
      "2024-08-07T17:30:00+00:00": 187.4199981689453,
      "2024-08-07T18:30:00+00:00": 186.6300048828125,
      "2024-08-07T19:30:00+00:00": 187.24000549316406
    },
    "sentiment": 0.8527796864509583
  },
  {
    "title": "Elliott Wave Technical Analysis: AbbVie Inc.",
    "published": 1723001880,
    "day_prices": {
      "2024-08-07T13:30:00+00:00": 187.89999389648438,
      "2024-08-07T14:30:00+00:00": 188.25999450683594,
      "2024-08-07T15:30:00+00:00": 188.0800018310547,
      "2024-08-07T16:30:00+00:00": 187.6300048828125,
      "2024-08-07T17:30:00+00:00": 187.4199981689453,
      "2024-08-07T18:30:00+00:00": 186.6300048828125,
      "2024-08-07T19:30:00+00:00": 187.24000549316406
    },
    "sentiment": 0.9456067681312561
  },
  {
    "title": "Bristol-Myers Squibb: A Potential Comeback In Healthcare",
    "published": 1722954774,
    "day_prices": {
      "2024-08-06T13:30:00+00:00": 185.42999267578125,
      "2024-08-06T14:30:00+00:00": 186.0800018310547,
      "2024-08-06T15:30:00+00:00": 186.55999755859375,
      "2024-08-06T16:30:00+00:00": 186.5500030517578,
      "2024-08-06T17:30:00+00:00": 186.77000427246094,
      "2024-08-06T18:30:00+00:00": 187.35000610351562,
      "2024-08-06T19:30:00+00:00": 186.70750427246094
    },
    "sentiment": 0.6763783693313599
  },
  {
    "title": "Is Invesco Large Cap Value ETF (PWV) a Strong ETF Right Now?",
    "published": 1722939607,
    "day_prices": {
      "2024-08-06T13:30:00+00:00": 185.42999267578125,
      "2024-08-06T14:30:00+00:00": 186.0800018310547,
      "2024-08-06T15:30:00+00:00": 186.55999755859375,
      "2024-08-06T16:30:00+00:00": 186.5500030517578,
      "2024-08-06T17:30:00+00:00": 186.77000427246094,
      "2024-08-06T18:30:00+00:00": 187.35000610351562,
      "2024-08-06T19:30:00+00:00": 186.70750427246094
    },
    "sentiment": 0.5826560258865356
  },
  {
    "title": "Worried About a Market Correction? 2 High-Yield Dividend Stocks You Can Buy Now and Hold Forever.",
    "published": 1722851760,
    "day_prices": {
      "2024-08-05T13:30:00+00:00": 187.4499969482422,
      "2024-08-05T14:30:00+00:00": 184.64999389648438,
      "2024-08-05T15:30:00+00:00": 185.02000427246094,
      "2024-08-05T16:30:00+00:00": 185.85000610351562,
      "2024-08-05T17:30:00+00:00": 184.30999755859375,
      "2024-08-05T18:30:00+00:00": 184.3800048828125,
      "2024-08-05T19:30:00+00:00": 183.74000549316406
    },
    "sentiment": 0.8330727219581604
  },
  {
    "title": "High-Yield Harvest: 3 Of My Favorite Dividend Stocks For What's Next",
    "published": 1722756600,
    "day_prices": {},
    "sentiment": 0.9301533102989197
  },
  {
    "title": "Neurocrine Biosciences Delivering Strong Core Results, And Significant Pipeline Value Could Be On The Way",
    "published": 1722595760,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 190.97999572753906,
      "2024-08-02T14:30:00+00:00": 189.72000122070312,
      "2024-08-02T15:30:00+00:00": 186.7050018310547,
      "2024-08-02T16:30:00+00:00": 188.22000122070312,
      "2024-08-02T17:30:00+00:00": 188.55999755859375,
      "2024-08-02T18:30:00+00:00": 188.02999877929688,
      "2024-08-02T19:30:00+00:00": 188.52999877929688
    },
    "sentiment": 0.9467233419418335
  },
  {
    "title": "Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years",
    "published": 1722571260,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 190.97999572753906,
      "2024-08-02T14:30:00+00:00": 189.72000122070312,
      "2024-08-02T15:30:00+00:00": 186.7050018310547,
      "2024-08-02T16:30:00+00:00": 188.22000122070312,
      "2024-08-02T17:30:00+00:00": 188.55999755859375,
      "2024-08-02T18:30:00+00:00": 188.02999877929688,
      "2024-08-02T19:30:00+00:00": 188.52999877929688
    },
    "sentiment": 0.9341244697570801
  },
  {
    "title": "Should You Buy AbbVie (ABBV) After Q2 Beat, Guidance Raise?",
    "published": 1722526860,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 187.77000427246094,
      "2024-08-01T14:30:00+00:00": 188.94500732421875,
      "2024-08-01T15:30:00+00:00": 190.2050018310547,
      "2024-08-01T16:30:00+00:00": 190.4499969482422,
      "2024-08-01T17:30:00+00:00": 190.6649932861328,
      "2024-08-01T18:30:00+00:00": 189.7899932861328,
      "2024-08-01T19:30:00+00:00": 190.4250030517578
    },
    "sentiment": 0.8492197394371033
  },
  {
    "title": "AbbVie Completes Acquisition of Cerevel Therapeutics",
    "published": 1722514980,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 187.77000427246094,
      "2024-08-01T14:30:00+00:00": 188.94500732421875,
      "2024-08-01T15:30:00+00:00": 190.2050018310547,
      "2024-08-01T16:30:00+00:00": 190.4499969482422,
      "2024-08-01T17:30:00+00:00": 190.6649932861328,
      "2024-08-01T18:30:00+00:00": 189.7899932861328,
      "2024-08-01T19:30:00+00:00": 190.4250030517578
    },
    "sentiment": 0.7550034523010254
  },
  {
    "title": "AbbVie backs Q3 adjusted EPS view $2.92-$2.96, consensus $2.94",
    "published": 1722497220,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 187.77000427246094,
      "2024-08-01T14:30:00+00:00": 188.94500732421875,
      "2024-08-01T15:30:00+00:00": 190.2050018310547,
      "2024-08-01T16:30:00+00:00": 190.4499969482422,
      "2024-08-01T17:30:00+00:00": 190.6649932861328,
      "2024-08-01T18:30:00+00:00": 189.7899932861328,
      "2024-08-01T19:30:00+00:00": 190.4250030517578
    },
    "sentiment": 0.5313029885292053
  }
]